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A B S T R A C T
Background
It is well recognized that patients with high blood pressure (hypertension) in the community frequently fail to meet treatment goals
- a condition labeled as “uncontrolled” hypertension. The optimal way in which to organize and deliver care to patients who have
hypertension so that they reach treatment goals has not been clearly identified.
Objectives
To determine the effectiveness of interventions to improve control of blood pressure in patients with hypertension. To evaluate the
effectiveness of reminders on improving the follow-up of patients with hypertension.
Search strategy
All-language search of all articles (any year) in the Cochrane Controlled Trials Register (CCTR), Medline and Embase from June 2000.
Selection criteria
Randomized controlled trials (RCTs) of patients with hypertension that evaluated the following interventions:
(1) self-monitoring
(2) educational interventions directed to the patient
(3) educational interventions directed to the health professional
(4) health professional (nurse or pharmacist) led care
(5) organisational interventions that aimed to improve the delivery of care
(6) appointment reminder systems
Outcomes assessed were:
(1) mean systolic and diastolic blood pressure
(2) control of blood pressure
(3) proportion of patients followed up at clinic
Data collection and analysis
Two authors extracted data independently and in duplicate and assessed each study according to the criteria outlined by the Cochrane
Collaboration Handbook.
Main results
56 RCTs met our inclusion criteria. The methodological quality of included studies was variable. An organized system of regular review
allied to vigorous antihypertensive drug therapy was shown to reduce blood pressure (weighted mean difference -8.2/-4.2 mmHg, -
11.7/-6.5 mmHg, -10.6/-7.6 mmHg for 3 strata of entry blood pressure) and all-cause mortality at five years follow-up (6.4% versus
7.8%, difference 1.4%) in a single large RCT- the Hypertension Detection and Follow-Up study. Other interventions had variable
effects. Self-monitoring was associated with moderate net reduction in diastolic blood pressure (weighted mean difference (WMD): -
2.0 mmHg, 95%CI: -2.7 to -1.4 mmHg, respectively. Appointment reminders increased the proportion of individuals who attended
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for follow-up. RCTs of educational interventions directed at patients or health professionals were heterogeneous but appeared unlikely
to be associated with large net reductions in blood pressure by themselves. Health professional (nurse or pharmacist) led care may be
a promising way of delivering care, with the majority of RCTs being associated with improved blood pressure control, but requires
further evaluation.
Authors’ conclusions
Family practices and community-based clinics need to have an organized system of regular follow-up and review of their hypertensive
patients. Antihypertensive drug therapy should be implemented by means of a vigorous stepped care approach when patients do not
reach target blood pressure levels.
P L A I N L A N G U A G E S U M M A R Y
There is a paucity of evidence as to how care for hypertensive patients should be organized and delivered in the community to help
improve blood pressure control. This review aimed to determine the effectiveness of interventions whose objective was to improve
follow-up and control of blood pressure in patients taking blood pressure lowering drugs. We included studies that had as population
of interest adult patients with essential hypertension in an ambulatory setting. The interventions included all those that aimed to
improve blood pressure control. The outcomes assessed were mean systolic and diastolic blood pressure, control of blood pressure and
the proportion of patients followed up at clinic.
Fifty six randomised controlled trials met our inclusion criteria. The range of interventions used included (1) self-monitoring, (2)
educational interventions directed to the patient, (3) educational interventions directed to the health professional, (4) health professional
(nurse or pharmacist) led care, (5) organizational interventions that aimed to improve the delivery of care, (6) appointment reminder
systems. The trials showed a wide variety of methodological quality, part of which may be attributed to poor reporting. An organized
system of regular review allied to vigorous antihypertensive drug therapy was shown to reduce blood pressure and all-cause mortality in
a single large RCT- the Hypertension Detection and Follow-Up study. Other interventions had variable effects. Self-monitoring was
associated with moderate net reductions in diastolic blood pressure (weighted mean difference (WMD): -2.0 mmHg, 95% confidence
interval (CI): -2.7 to -1.4 mmHg. Appointment reminders increased the proportion of individuals who attended for follow-up (absolute
difference 16%, but this pooled result should be treated with caution because of the heterogeneous results from individual RCTs). Trials
of educational interventions directed at patients or health professionals were heterogeneous but appeared unlikely to be associated with
large net reductions in blood pressure by themselves. Health professional (nurse or pharmacist) led care appears to be a promising way
of delivering care but requires further evaluation.
We conclude that an organized system of registration, recall and regular review allied to a vigorous stepped care approach to anti-
hypertensive drug treatment appears the most likely way to improve the control of high blood pressure. Health professional (nurse
or pharmacist) led care requires further evaluation. Education alone, either to health professionals or patients, does not appear to be
associated with large net reductions in blood pressure.
B A C K G R O U N D
High blood pressure (hypertension) is an important public health
problem. Evidence from randomized trials has shown that effective
drug treatment reduces the risk of cardiovascular morbidity and
mortality (Collins 1994; Gueyffier 1999). However, there is on-
going concern that the benefits demonstrated in randomized trials
of antihypertensive drug treatment are not implemented in every-
day clinical practice (Burnier 2002). Community-based studies
throughout the world show that blood pressure goals are achieved
in only 25-40% of the patients who take antihypertensive drug
treatment (Burnier 2002; Hyman 2001; Chobanian 2001; Smith
1990), a situation that has remained unchanged for the last 30
years (Wilber 1972).
The quality of care patients with hypertension receive from health
professionals has a clear impact on their risk of suffering a car-
diovascular event. Observational studies in the UK have shown
that inadequate control of blood pressure is associated with a sig-
nificant risk of stroke (Du 1997; Payne 1993). In terms of the
process of care that hypertensive patients receive, characteristics
of both the patient, health professional and the healthcare system
in which they are given their medical care have been implicated
in poor blood pressure control. Lack of adherence to medication
and not having a primary care physician were associated with poor
blood pressure control in a US study (Shea 1992). More recent
studies have shown that frequent contact with health care pro-
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fessionals does not guarantee better blood pressure control un-
less there is more vigorous use of antihypertensive drugs (Hyman
2001; Berlowitz 1998), and that individual practitioners vary sub-
stantially in their clinical performance when managing hyperten-
sion in the community (Frijling 2001). These observations have
led some commentators to suggest that poor control of blood pres-
sure in the community may be due to ineffective management
and inadequate practice organisation, described jointly as “clinical
inertia” (Phillips 2001).
Whilst there is a strong evidence-base for the benefits of anti-
hypertensive drug therapy (Collins 1994; Blood 2000; Staessen
2001), there is little clear evidence as to how care for hypertensive
patients should be organized and delivered in the community to
help improve blood pressure control. This systematic review aims
to update and build upon a previous review (Ebrahim 1998), to
summarize the evidence from randomized controlled trials that
evaluate different models of care that have been used to improve
the control and follow-up of patients with hypertension.
O B J E C T I V E S
The objectives of this review are to:
(1) Evaluate which models of care are effective in improving “con-
trol” of high blood pressure;
(2) Evaluate the effectiveness of reminders on improving the fol-
low-up of patients with hypertension.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Randomized trials of interventions that have sought to evaluate
different models of care for patients with hypertension with the
overall aim of improving blood pressure control or follow-up care
of patients. Included studies had to be RCTswith a contemporane-
ous control group where patient care in the intervention group(s)
was compared with either no intervention or usual care. We ex-
cluded studies using interventions not intended to increase blood
pressure control by organisational means, particularly drug trials
and trials of non-pharmacological treatment.
Types of participants
The populationof interestwas composed of adult patients (aged 18
years or over) with essential hypertension (treated or not currently
treated with blood pressure lowering drugs) in a primary care,
outpatient or community setting.
Types of intervention
The interventions were aimed at improving control of blood pres-
sure or clinic attendance and were classified as:
(1) self-monitoring
(2) educational interventions directed to the patient
(3) educational interventions directed to the health professional
(4) health professional (nurse or pharmacist) led care
(5) organisational interventions that aimed to improve the delivery
of care
(6) appointment reminder systems
Types of outcome measures
Studies were included if they reported:
(1)mean systolic bloodpressure (meanSBP) and/ormean diastolic
blood pressure (mean DBP)
(2) control of blood pressure (blood pressure threshold that deter-
mines “control” being pre-specified or defined by each random-
ized trial’s investigators)
(3) proportion of patients followed-up at clinic
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: methods used in reviews.
We identified original RCTs by an all-language search of all
articles in the Cochrane Central Register of Controlled Trials
(CENTRAL), from The Cochrane Library issue 2, 2004; from
MEDLINE January 2000 to July 2004; and EMBASE January
2000 to July 2004. We screened the references of all retrieved
articles to identify additional publications and contacted experts
in the field about other relevant trials or unpublished material.
We used the following search strategy:
1. exp HYPERTENSION/
2. exp Antihypertensive Agents/
3. (blood adj pressure).ti.
4. hypertens$.tw.
5. or/1-4
6. exp PHYSICN/
7. exp Patient Care Management/
8. exp Patient Care Planning/
9. exp Patient Care Team/
10. exp Patient Education/
11. exp Patient Participation/
12. exp Ambulatory Care Information Systems/
13. exp FEEDBACK/
14. exp Information Systems/
15. exp Management Information Systems/
16. exp Decision Support Systems, Clinical/
17. exp Decision Making, Computer-Assisted/
18. exp Reminder Systems/
19. exp Practice Guidelines/
20. exp GUIDELINES/
21. exp Medical Audit/
22. exp Medical Records/
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23. exp “Outcome and Process Assessment (Health Care)/
24. exp Medical Records Systems, Computerized/
25. exp Primary Health Care/
26. exp Physicians, Family/
27. exp Primary Nursing Care/
28. exp Nurse Practitioners/
29. exp Nurse Clinicians/
30. exp Health Behavior/
31. remind$.tw.
32. motiv$.tw.
33. Patient Care/
34. Nursing Care/
35. Guideline Adherence/
36. Ambulatory Care/
37. exp Behavior Therapy/
38. Counseling/
39. counsel$.tw.
40. Motivation/
41. self monitor$.tw.
42. ((patient$ or program$) adj3 (educat$ or manage$ or train$
or teach$)).tw.
43. self manage$.tw.
44. ((manage$ or monitor$) adj3 (hypertension or blood
pressure)).tw.
45. Health Promotion/
46. exp Health Education/
47. (reward$ or incentivtte$)
48. uncontrol$.tw.
49. Self Care/
50. or/6-49
51. 5 and 50
52. randomized controlled trial.pt.
53. controlled clinical trial.pt.
54. Randomized Controlled Trials/
55. random allocation/
56. double blind method/
57. single blind method/
58. or/52-57
59. animal/ not human/
60. 58 not 59
61. clinical trial.pt.
62. exp clinical trials/
63. (clin$ adj25 trial$).ti,ab.
64. ((singl$ or doubl$ or treble$ or tripl$) adj25 (blind$ or
mask$)).ti,ab.
65. placebos/
66. ”placebo$.ti,ab.
67. “random$.ti,
68. research design/
69. or/61-68
70. 69 not 59
71. comparative study/
72. exp evaluation studies/
73. follow-up studies/
74. prospective studies/
75. (control$ or prospectiv$ or volunteer$).ti,ab.
76. or/71-75
77. 76 not 59
78. 60 or 70 or 77
79. 51 and 78
80. 60 or 70
81. 51 and 80
82. limit 81 to yr=2000-2002
This search strategy was slightly amended for searching
Cochrane Central Register of Controlled Trials (CENTRAL)
and EMBASE.
M E T H O D S O F T H E R E V I E W
Two of the authors (TF and KS) assessed lists of citations and
abstracts independently. We were not masked with regard to
authors or journal. Each reviewer indicated whether a citation
was potentially relevant (i.e. appearing to meet the inclusion
criteria), was clearly not relevant, or gave insufficient information
to make a judgement. To be included a study had to meet all
the inclusion criteria. We resolved differences by discussion and
obtained reprints of all potentially relevant citations.
We (TF and either KS or SE) independently extracted data
in duplicate on study design, methods, clinicians and patients,
interventions, outcomes and potential sources of bias using a
structured data collection form. We wrote to the corresponding
authors of studies to request missing data, clarify study details and
enquire about unpublished studies.
For assessment of study qualitywe collected data on randomization
procedure, allocation concealment, blinding of participants,
providers of care, outcome assessors and losses to follow-up (Clarke
2000).
We examined the effects on blood pressure between interventions
at follow-up (systolic and diastolic blood pressure) according to
the six pre-defined intervention categories. We compared and
pooled the mean blood pressure differences from baseline to
final follow-up in the intervention and control groups using the
weighted mean difference approach (see Cochrane Heart Group
website: http://www.epi.bris.ac.uk/cochrane/stats3.html). When
only partial information about the variance was provided in RCT
reports, we calculated variances using the method described by
Follman (Follman 1992).We have taken account of the correlation
of baseline and final blood pressure measurements by using
empirical data from the Caerphilly dataset which examined the
correlation between baseline and 5-year follow-up blood pressure
measurements in 2000 men (r=0.568 for systolic and r=0.514 for
diastolic blood pressure) (personal communication Margaret May,
Department of Social Medicine, University of Bristol).
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For blood pressure control and clinic attendance at follow-up
statistical and clinical significance was evaluated by means of
estimating odds ratios with 95% confidence intervals. Individual
study definitions of control of blood pressure and attendance
at clinic were used. For both continuous and categorical
outcomes, we checked the meta-analyses for heterogeneity by
visual inspection and by Cochran’s test. When heterogeneity is
significant, the individual study results are presented to illustrate
the magnitude of blood pressure reduction reported but no
overall pooled results are presented. Pooled odds ratios and their
95% confidence intervals were calculated with The Cochrane
Collaboration RevMan 4.1 software.
D E S C R I P T I O N O F S T U D I E S
Fifty six randomized controlled trials met the inclusion criteria.
Three randomised controlled trials had a factorial design and are
included twice under separate intervention headings - Pierce (self-
monitoring and education- patient) (Pierce 1984), Sackett (educa-
tion- patient and organisation of care) (Sackett 1975), and Dick-
inson (education- health professional and organisation of care)
(Dickinson 1981). A further RCT was a three armed study of pa-
tient education, home monitoring from a family member actively
participating in their care and a usual care arm (Earp 1982).
M E T H O D O L O G I C A L Q U A L I T Y
The reported methodological quality of included studies was gen-
erally poor to moderate. Nineteen randomised controlled trials
(32%) stated the randomization process, whilst only six (10%)
had adequate allocation concealment. In 11 studies (19%) the
outcome assessors were blind to the treatment allocation. Losses
to follow-up of greater than 20% or more occurred in 12 (20%)
of studies.
For a detailed summary of each of the 56 included RCTs see Table
01.
R E S U L T S
(1) Self-monitoring (n=15 RCTs) (Pierce 1984; Bailey 1998; Car-
nahan 1975; Friedman 1996;Haynes 1976; Johnson 1978;Mehos
2000; Rogers 2001; Soghikian 1992; Vetter 2000; Zarnke 1997;
Artinian 2001; Midanik 1991; Rudd 2004; Earp 1982).
In the ten RCTs that reported on differences in mean SBP
(Carnahan 1975; Soghikian 1992; Friedman 1996; Bailey 1998;
Mehos 2000; Vetter 2000; Rogers 2001; Artinian 2001; Midanik
1991; Rudd 2004), self-monitoring was associated was associ-
ated with significant between-group heterogeneity for mean SBP
(range -10 to +5mmHg). Pooled data from twelve RCTs on dif-
ference of mean DBP (Carnahan 1975; Soghikian 1992; Fried-
man 1996; Bailey 1998; Mehos 2000; Vetter 2000; Rogers 2001;
Haynes 1976; Johnson1978; Artinian2001;Midanik 1991;Rudd
2004),showed that self-monitoring was associated with a signifi-
cant reduction of -2.0 mmHg (95% CI -2.7 to -1.4 mmHg). In
the four RCTs that reported on control of blood pressure (Pierce
1984,Rogers 2001; Vetter 2000; Earp 1982), there was a trend
towards improved blood pressure control but this was not signifi-
cant (odds ratio 0.9 (95%CI 0.7 to 1.2). The remaining RCT that
did not report any usable data concerning blood pressure control,
reported a mean arterial blood pressure difference of 3mmHg in
favour of the intervention (Zarnke 1997). However, this RCT was
of a short duration (8 weeks follow-up).
(2) Educational interventions directed to the patient (n=16 RCTs)
(Pierce 1984; Sackett 1975; Billault 1995; Burrelle 1986; Earp
1982; Fielding 1994; Gullion 1987; Hamilton 1993; Martinez-
Amenos 1990;Morisky 1983 and Levine 1979;Muhlhauser 1993;
Roca-Cusachs 1991; Tanner 1981; Watkins 1987; Webb 1980;
Zismer 1982) .
Seven RCTs reported mean difference SBP, nine RCTs reported
mean difference DBP and five on BP control. For mean differ-
ence in SBP andDBP outcomes pooling of results from individual
RCTs produced heterogeneous results, so pooled mean differences
are not valid. Mean difference in SBP was reported with a range
of difference in mean SBP reported between -15.7 mmHg to +0.6
mmHg, mean difference in DBP was reported with a range DBP
-8.7 mmHg to +7.1 mmHg. In terms of blood pressure control
(five RCTs) there was a trend towards improved blood pressure
control but this was not significant (odds ratio 0.7 (95%CI 0.4 to
1.0). Three RCTs did not report relevant outcome data (Gullion
1987; Hamilton 1993; Martinez-Amenos 1990), but did report
increases in patient knowledge (Martinez-Amenos 1990). Two of
these RCTs reported no difference in blood pressure control (Gul-
lion 1987; Martinez-Amenos 1990). One RCT reported an im-
provement in SBP but not DBP at 6months follow-up (Hamilton
1993).
(3) Educational interventions directed to the physician (n=9
RCTs) (Dickinson 1981; Coe 1977; Evans 1986; Hetlevik 1998;
McAlister 1986; Montgomery 2000; Ornstein 2004; New 2004;
Sanders 2002).
Educational interventions directed towards the physician were as-
sociated with a small reduction in systolic blood pressure, pooled
mean difference in SBP was -2.0 mmHg, 95% CI -3.5 to -0.6
mmHg. However, educational interventions directed at the physi-
cian were not associated with a significant decrease in mean DBP
(mean difference -0.4 mmHg, 95% CI -1.1 to +0.3 mmHg)
whilst control of blood pressure produced heterogeneous results
(reported range 0.8 to 1.0).
(4) Health professional (nurse or pharmacist) led care (n=7 RCTs)
( Bogden 1998; Garcia-Pena 2001; Hawkins 1979; Jewell 1988;
Logan 1979; Park 1996; Solomon 2002).
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Health professional (nurse or pharmacist) led care may be a
promising way of delivering care, with the majority of RCTs be-
ing associated with improved blood pressure control. For all three
outcomes pooling of results from individual RCTs produced het-
erogeneous results, so pooledmean differences are not valid. Mean
difference in SBP was reported in five RCTs with a range of dif-
ference in mean SBP from -13 mmHg to 0 mmHg. Mean differ-
ence in DBP was reported in six RCTs, ranging from -8 mmHg
to 0 mmHg. Control of blood pressure produced heterogeneous
results (reported range 0.1 to 0.9).
(5) Organisational interventions that aimed to improve the de-
livery of care (n=7 RCTs) (Sackett 1975; Dickinson 1981; Brook
1983; Bulpitt 1976; Hypertension 1979; Hypertension 1979a;
Hypertension 1982; Robson 1989; Takala 1979; Takala 1983).
For all three outcomes pooling of results from individual RCTs
produced heterogeneous results, so pooled mean differences are
not valid and the range of mean difference in SBP and DBP is
illustrated in MetaView. Of note, the largest RCT, the Hyperten-
sion Detection and Follow-Up Program (HDFP), produced sub-
stantial reductions in SBP and DBP across the three groups in this
RCT (patient were stratified according to level of entry DBP level,
weighted mean difference -8.2/-4.2 mmHg, -11.7/-6.5 mmHg, -
10.6/-7.6 mmHg for the three strata of entry blood pressure) ).
At five year follow-up these reductions in blood pressure were as-
sociated with a significant reduction in all cause mortality at five
years follow-up (6.4% versus 7.8%, risk difference 1.4%).
(6) Appointment reminder systems (n=6 RCTs) (Ahluwalia 1996;
Barnett 1983; Bloom 1979; Cummings 1985; Fletcher 1975;
Krieger 1999).
In five RCTs reminder systems were associated with an improve-
ment in follow-up. One RCT of a mailed postcard reminder was
not associated with improved follow-up (Ahluwalia 1996). The
pooled results though favouring appointment reminder systems
for follow-up of patients, odds ratio of being lost to follow-up
0.4, 95% confidence interval (CI) 0.3 to 0.5 are heterogenous be-
cause of the single outlying RCT and the pooled results should
be treated with caution. Four other RCTs (studies classified under
the other intervention headings but incorporated some form of
reminder intervention such as postal reminders or computer gen-
erated feedback) were associated with significantly improved fol-
low-up attendance by patients (Dickinson 1981; Hamilton 1993;
Hawkins 1979; Takala 1979; Takala 1983).
D I S C U S S I O N
Key findings from this review
The main finding from this systematic review are to a large ex-
tent dominated by the findings from the largest RCT, the HDFP
study (Hypertension 1979; Hypertension 1979a; Hypertension
1982). Though partly intended as a trial to assess the value of sys-
tematic identification of hypertensive patients (Davis 2001), the
key ingredients of how patients with established hypertension and
taking antihypertensive drug treatment were managed- free care,
registration, recall and regular review in tandem with a rigorous
stepped care approach to antihypertensive drug treatment- should
be emphasized as this multi-faceted intervention was effective in
terms of reaching blood pressure goals and reducing all-cause mor-
tality. It is interesting to note that a two-year post trial surveillance
study showed that blood pressure control was attenuated when
the stepped-care arm of the study was discontinued. This lack of
control was associated with a decline in the use of antihypertensive
medication (Hypertension 1986).
Other interventions assessed in this systematic review did not pro-
duce clear results. None of the interventions were associated with
large, clinically important, reductions in either systolic or diastolic
pressure, seeMetaView. Self-monitoring was associated with a sig-
nificant decline in diastolic blood pressure and further evaluation
in larger RCTs is warranted. Education alone, directed either to
patients or health professionals appears unlikely to influence con-
trol of blood pressure as a single intervention, as results were highly
heterogeneous or of marginal clinical importance. Use of health
care professionals such as nurses and pharmacists, though produc-
ing significantly heterogeneous results, did havemainly favourable
effects, and merit further definitive evaluation in larger RCTs.
Lastly, reminders (postal or computer-based) were associated with
an improvement in the follow up of patients with hypertension
in all RCTs aside from one small study. This finding is consistent
with the organisational structure of the HDFP study and re-iter-
ates the importance of systematic recall systems when organising
care for hypertensive patients.
Context of other studies
There are elements identified from this review that appear to be as-
sociated with improved blood pressure control and are consistent
with findings from observational studies and previous systematic
reviews. In a large community-based study, patients who received
intensive antihypertensive drug therapy were significantly more
likely to have reduced systolic blood pressure of 6.3 mmHg com-
pared to an increase of 4.8mmHg in those who received less inten-
sive antihypertensive drug therapy (Berlowitz 1998). A more re-
cent observational study showed that antihypertensive drug ther-
apy was initiated or changed in only 38% of episodes of care,
despite documented uncontrolled hypertension for at least six
months (Davis 2001; Davis 2001; Davis 2001; Oliveria 2002).
Lack of practice organisation is associated with a failure to achieve
treatment surrogate goals in hypertension, diabetes and secondary
prevention of coronary heart disease (Phillips 2001). A recent sys-
tematic review of self monitoring also produced similar findings
of modest but potentially important benefit (Cappuccio 2004).
We have found substantially more RCT evidence in terms of hy-
pertension management than a recent systematic review that ex-
amined interventions used in disease management programmes
for patients with chronic illness (Weingarten 2002). In this re-
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view, eight hypertension-related RCTs were cited which provided
some evidence of benefit in terms of education directed at the
patient and provider (health professional) (Weingarten 2002). In
this systematic review of 56 RCTs, the subset of RCTs where the
intervention was directed at the patient (n=16) or physician (n=9)
does not support this finding, showing no clinically important ev-
idence for patient or health professional education as an effective
implementation strategy in the management of hypertension.
Study limitations
There are several shortcomings that need to be highlighted in this
systematic review. The HDFP study was designed as an interven-
tion that would identify newly diagnosed hypertensive patients
and then start or modify antihypertensive treatment in those with
untreated as well as uncontrolled hypertension (Davis 2001). A
consequence of this study design is that a differential number of
people were receiving antihypertensive drug treatment in the two
arms, percentage of patients taking antihypertensive medication -
higher for stepped care 81.2%, compared to referred care 64.2%
at follow-up in year 5 (see details on included studies). So though
it appears that the systematic follow-up and stepped care approach
in HDFP is an important element in effective clinical care and
prompts rigorous antihypertensive drug treatment, it is not pos-
sible to distinguish between the independent effect of these inter-
ventions on blood pressure control. Several other RCTs included
both treated and untreated hypertensive patients and had differ-
ential rates of antihypertensive drug prescribing (Vetter 2000; Mi-
danik 1991; Rudd 2004; Ornstein 2004), with rates of prescribing
at higher levels in the intervention arm at follow up. Secondly,
many RCTs contained multi-faceted interventions that did not
fit into a single intervention category. For example several RCTs
that were included under categories of patient education, physi-
cian education, health professional led care and organisation of
care also incorporated some form of reminder intervention such
as postal reminders or computer generated feedback (Dickinson
1981;Hamilton1993;Hawkins 1979;Takala 1979;Takala 1983).
Consequently, it has been difficult to attribute how far single ele-
ments thatmake up complex interventions exert their independent
effect on blood pressure control. In terms of self monitoring, it is
well established that ”office“ blood pressure readings are around
10/5mmHg higher when compared to ambulatory or self mon-
itored readings (Staessen 1997; Staessen 2004; Williams 2004).
Several of the RCTs did not make any recommendations about
the need for adjustment of target blood pressure readings when
self monitoring was the intervention being assessed, nor did they
appear to anticipate lower blood pressure readings in the self mon-
itoring group (Bailey 1998; Johnson 1978; Pierce 1984). Thismay
have attenuated the impact of self monitoring on blood pressure
control because of failure to intensify treatement. Poor adherence
to therapy is thought to be associated with poor control of blood
pressure (Shea 1992). Only a few trials examined the relation
between adherence to medication and control of blood pressure
(Haynes 1976; Johnson 1978; Sackett 1975). Future studies will
need to be designed to assess the relationship between poor adher-
ence and poor response to antihypertensive drugs in patients with
good adherence. Lastly, not all RCTs reported on the outcomes of
blood pressure achieved or blood pressure control. This has meant
that the relevant a priori outcomes have not been reported for all
included RCTs, and pooling of data from all RCTs has not been
possible.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Despite these limitations important messages emerge from this
systematic review. Effective delivery of hypertensive care requires
a systematic approach in the community, incorporating regular
review of patients and a willingness to intensify antihypertensive
drug treatment, usually by adding additional classes of antihyper-
tensive drugs, when blood pressure goals are not being met (Hy-
pertension 1979; Hypertension 1979a; Hypertension 1986Davis
2001). This approach of intensive drug therapy and ”tight“ control
of blood pressure has been demonstrated to be possible in clinical
trials in hypertensive and diabetic patients alike (Hansson 1999;
UK PDS 1998). There are reports of successful systematic care
of hypertensive patients in the community over a 20 year period
(Hart 1991), but the challenge is to translate these findings into
usual clinical care.
Implications for research
In terms of future studies, careful preliminary work is neededwhen
developing and testing complex interventions and thought needs
to be given as to how their individual and combined effects are
measured (Campbell 2000). Aside from definitive RCTs exam-
ining the effects of self-monitoring and allied health professional
led care (pharmacist and nurses), there is also a paucity of evi-
dence in terms of computer-based clinical decision support systems
(CDSSs) in hypertension and how adherence-enhancing strate-
gies influence subsequent blood pressure control (Ebrahim 1998).
HDFP was a well-funded study with substantial staffing resources.
This meant that the ”stepped care“ intervention was provided by a
highlymotivated workforce. An economic evaluation of delivering
organised care to hypertensive patients should accompany future
studies. Lastly, none of the included RCTs attempted to manage
hypertension in the context of overall cardiovascular risk. Future
studies need to be congruent with hypertension guidelines that
recommend treatment and control of blood pressure in combina-
tion with multi-factorial risk reduction (Ramsay 1999).
Conclusions
Effective delivery of hypertension care in the community requires
a rigorous approach in terms of identification, follow-up and treat-
ment with antihypertensive drugs. This systematic review shows
that such an approach is likely to translate into reductions in car-
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diovascular mortality and morbidity (Hypertension 1979; Hyper-
tension 1979a; Hypertension 1986; Davis 2001). Supplementary
and alternative models of care, including self monitoring of blood
pressure by patients, blood pressure management by allied health
care professionals and CDSSs require further development and
evaluation. Educational interventions directed to either patients
or health professionals alone are unlikely to produce clinically im-
portant reductions in either systolic or diastolic blood pressure.
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T A B L E S
Characteristics of included studies
Study Ahluwalia 1996
Methods Parallel, individuals, hospital outpatients in a single hospital clinic, USA
Participants Hypertensive (SBP 180mmHg and/or DBP 110mmHg), 95% African American, 49% uninsured, mean age
56
Interventions (1) Mailed reminder- postcard addressed in the presence of the patient and mailed next day as a reminder to
attend clinic in a week’s time
(2) No reminder card, given routine clinic appointment
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Outcomes (1) First follow up visit to walk-in clinic or a continuity medicine clinic- no difference at 6 months (E) 45/53,
85% versus (C) 48/54, 89%
Duration of FU 6 months
Notes No blood pressure data collected at outcome
Allocation concealment B – Unclear
Study Artinian 2001
Methods Pilot RCT
Participants Age >18 years, SBP >140mmHg or >90mmHg or for diabetic patients ?130mmHg or ?85mmHg
Interventions (1) Home BP telemonitoring- self monitoring at home and transmitting BP readings over telephone line
to care providers in order to ”facilitate telecounselling and treatment planning“. BP readings transmitted 3
times per week for 12 weeks. (2) Nurse-managed community based BP monitoring.(3) Usual care
Outcomes (1) Blood pressure- mean change SBP 25 mmHg, mean change DBP 14mmHg (E) versus mean change SBP
+1 mmHg, mean change DBP 2mmHgDuration of FU 3 months
Notes Small pilot study with short follow up period
Allocation concealment B – Unclear
Study Bailey 1998
Methods Parallel, individuals based in general practitioner surgeries, Australia
Participants Patients who were about to start BP lowering treatment who did not practice self-measurement, <7% previ-
ously untreated, mean age 53.5 years.
Interventions (1) Self monitoring- use of an OMRON HEM706 monitor. Asked to record BP twice daily for 8 weeks
(2) Usual care- no self recording
Outcomes (1) Blood pressure control- significantly worse (E) 148/89mmHg versus (C) 142/89.
(2) Process of medical care-more vigorous in (C) group in terms of increase, addition of medication
(3) Compliance (pill count) (E) 88% versus (C) 94% NS
Duration of FU 8 weeks
Notes 23% patients were not interested in future self-measurement
Outcome assessment: 24 hour ambulatory monitoring
Physicians not instructed to achieve a treatment goal or protocol
Significant disagreement between self monitoring and office measurement found by 19% physicians and
16% patients. In (E) group negative finding most likely due to the fact that physicians were less likely to alter
drug regimen when self-measurement readings were lower than office BP measurement. Finding most likely
to due different responses to process of care
no protocol concerning treatment intensification was provided in this RCT. No adjustment to the lower self
monitor readings were made and no intensification was associated with the intervention
Allocation concealment B – Unclear
Study Barnett 1983
Methods Parallel, individuals based in one community-based health centre in USA.
Participants Physicians
nurse-practitioners
(numbers not stated). Patients (n= 115) with sustained hypertension and/or diagnosis of hypertension and
placed on therapy, <2 repeat BP measurements after initial visit. 49% female, mean age 43 years (42% older
than 45 years), 17% black
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Characteristics of included studies (Continued )
mean initial BP 150/102mmHg, 7%with history of hypertension, 4% with history of cardiovascular disease,
15% with family history of hypertension, 34% diagnosed obese
Interventions (1) Computer reminder to GP- automated surveillance system utilizing computer-based medical record
system, generated automatic reminder to GP to check BP of patients. ”No attempt was made to monitor the
quality of care as to the degree of BP control“.
(2) Usual care.
Outcomes (1) Evaluate extent BP FU was attempted or achieved, (E) 62/63 (98%) versus (C) 24/52 (46%).
(2) Repeat BP recorded (E) 44/63 (70%) versus (C) 27/52 (52%).
(3) Degree of DBP control achieved (DBP <100mmHg) (E) 44/63 (70%) versus (C) 27/52 (52%).
Duration of FU 24 months.
Notes Intervention improved follow up of patients and in those who were followed up DBP was significantly
improved.
Stratified according to age ( 45) and DBP ( 100mmHg)
Allocation concealment B – Unclear
Study Billault 1995
Methods Parallel, individuals in a single outpatient clinic, Paris, France.
Participants Individuals who attended hypertension clinic, no entry SBP/DBP defined, 88% (C) 83% (E) on BP lowering
drugs.63% male
Interventions (1) Booklet with personalised standardised medical information explained to patient and their family doctor.
Ten items included on the basis of usefulness of managing hypertension. Patients asked to complete with
family doctor and mail carbon copy to outpatient clinic for entry into computerised record.(2) Usual care
Patients in both groups encouraged to visit family doctor 1-3 times per trimester according to severity of
hypertension
Outcomes (1) Process of care in terms of use of services.(2) SBP/DBP- (E) 145.1/88.2mmHg versus (C) 146.2/86.8; no
difference between groups (3) Other cardiovascular risk factors (smoking, exercise, body weight- no difference
between groups.Duration of FU 1 year
Notes 44/82 (54%) of intervention group who were followed up completed personal medical record.
Allocation concealment B – Unclear
Study Bloom 1979
Methods Parallel, individuals based after a work-site screening programme US
Participants Patients with elevated blood pressure 140/90mmHg.
Average age 40, white, male 82%, well educated 60% with a masters degree or higher
Interventions (1) Educationalmaterial about hypertension, reinforced by a hypertension counsellor oneweek later, designed
to improve appointment keeping and knowledge
(2) No educational material or counsellor follow up.
Outcomes (1) Number seeking medical care/appointment- significantly improved 15/27 (E- 55.5%), 7/27 (C- 25.9%)
(2) Knowledge about hypertension- increased in (E) 3.22 versus (C) 2.26
Duration of FU 3 months
Notes RCT concerned with initial follow up of patients identified as having sustained hypertension after screening
programme
Allocation concealment B – Unclear
Study Bogden 1998
Methods Parallel, individuals in a single OPD clinic in US
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Characteristics of included studies (Continued )
Participants Patients with increased blood pressure, either:
150 or 95mmHg
140 or 90mmHg with CVS risk factors or target organ damage
Mean age 55 sd13, 25% mixed Hawiian ancestory, 57% high school graduates, 87% health insurance
Interventions (1) Pharmacist interacted with physicians and patients:
Patients:
“Go through medication history
”Answered questions
“Encouraged compliance
Physicians:
”Reviewed laboratory data with doctors
“Attached ”recommendations“ about blood pressure treatment
Control: usual medical care without pharmacist involvement
Outcomes (1) % patients with controlled BP (<140 and <90mmHg)- improved 27/49 (E) 9/46 (C) p<0.001
(2)Mean reduction in SBP/DBP at follow up- improved (E) 132/85mmHg versus (C) 145/92mmHg p<0.01
(3) Mean medication cost decreased $6.8 (E) increased $6.5 (C)
Duration of FU 16 months
Notes No contamination between doctors
Intervention superior to usual care
Process of care in intervention arm. Pharmacist made 162 recommendations to doctors:
10 new (additional) medication to be started
34 medication dose increase
12 stop medication
5 reduce medication due to side effects
16 renew medication at existing dosage
52 switch to a cheaper drug
20 newer more effective drug
Allocation concealment B – Unclear
Study Brook 1983
Methods Cluster RCT, families unit of randomisation
Participants 2005 Families living in six US cities (47% men, 18% non white, mean age 33.4, range 14-61) Results are
reported for subset of hypertensive subjects, 24.7% (n=294) full health insurance, 24.5% (n=562) partial
health insurance.
Interventions (1) Full health insurance-(2) Partial health insurance (three groups at different levels of re-imbusement:(a)
Individual - 95% OPD to ceiling of $150, all inpatient(b) Intermediate- 25-50% both OPD and inpatient
up to $1000(c) Catastrophic- 95% both OPD and inpatient up to $1000
Outcomes (1) Mean DBP- improved by -1.9mmHg(2) Mean SBP- improved by -1.8mmHg(3) General health(4)
Health habits(5) Risk of dyingDuration of FU: 3 years
Notes SBP/DBP reported but baseline DBP lower than follow up (see tables 3 and 5 in original report). Subsequent
report suggested lower SBP/DBP at followup adjusted for blood pressure at baseline (see table 2 and text).high
losses to FUNo details on process of BP care, but free care increased physician contacts and better lifestyle
changesSubgroup analysis: Low-income people with high BP had greater improvement than high-income--
3.5mmHg (low income) versus 1.1mmHg (high-income)
Allocation concealment B – Unclear
Study Bulpitt 1976
Methods Parallel, individuals based in 3 hospital hypertension clinics in UK
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Participants Intervention directed at hospital physicians (number not stated).
278 patients with diagnosed hypertension referred to clinics. Characteristics of patients: computer group:
56% female, mean age 51years, mean lying BP 178/105mmHg;
control group: 53% female, mean age 48 years, mean lying BP 177/106mmHg
Interventions (1) Computer-held records- allowed doctor to record clinical information in structured format.
(2) Standard hospital notes
Outcomes (1) Content of patient record 15 items- overall better recording in computer group
(2) Length of time of consultation- longer in E (39.9 mins) than C (31.4 mins) at initial consultation,
subsequent consultations no difference.
(3) Patient investigations during RCT- no difference
(4) Drop outs- 25/136 (E- 18%) 36/142 (C- 25%)
(4) Average SBP and DBP- no difference (E) 149/96mmHg (C) 149/97mmHg
Duration of FU 12 months.
Notes
Allocation concealment B – Unclear
Study Burrelle 1986
Methods Parallel, individuals, hospital outpatients and primary care, USA
Participants 16 treated and non-adherent elderly hypertensive patients, 75% black, 75% women, mean age 69.
Interventions (1) Home visits, education and special dosing devices; addressed psycho-social problems and compliance
problems by means of: medication planners; special dosing devices; individualized instruction on disease
states and treatments- Treatment Information on Medications for the Elderly (TIME)
(2) Usual care
Outcomes (1) Blood pressure control- no difference between groups, (E) 167.8/89.2mmHg versus (C)
165.8/86.8mmHg
(2) Compliance (Pill counts and direct questioning, taking >80% of medication)- Percent of pills taken: 92%
(E) versus 71% (C) (p<0.001)
(3) % with controlled hypertension, no difference, (E) 1/8, 13% versus (C) 1/8, 13%
Duration of FU 8 weeks
Notes Very small and underpowered study
Allocation concealment B – Unclear
Study Carnahan 1975
Methods Parallel
Individuals
Participants V A outpatient clinic US, starting treatment, n=100 (male 98), mean age 54 (E) 57 (C)
Interventions (1) SelfMonitoring, Instructed to use own sphygmomanometer twice a day. Readings recorded and delivered
to the clinic when visiting. (2) usual care
Outcomes (1) Mean SBP/DBP- SBP lower at 6 months FU in (E), 7.5mmHg difference
DBP no difference at FU
Duration FU: 6 months
Notes No SDs available, estimated to be 20mmHg SBP, 10mmHg DBP
Allocation concealment B – Unclear
Study Coe 1977
Methods Parallel, individuals based in 2 hospital hypertension clinics in US
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Participants Hospital physicians
(number not stated)
116 patients, 90.5% female, mean age 52years, all black
unselected, consecutive referrals to clinics during 6-month period. Characteristics:
(1)Mean of 3 separate pretreatment BP measurements >140/95mmHg
(2)Three return visits while on treatment
(3).BP medication taken as prescribed
Interventions (1) Computer-generated treatment recommendations by algorithm; generated drug type and dose recom-
mendations to physician
(2) Usual physician care
Outcomes (1) Blood pressure- reported in three strata of DBP, <95, 95-105, >105 but no differences between (E)
152.5/99.6mmHg versus (C) 148.7/96.5mmHg
(2) Compliance- self report, no difference
(3) Drugs prescribed- patterns of drug use the same.
Duration of FU months uncertain but weeks of treatment varied within a range of 21 to 40 weeks
Notes Difficult to interpret as trial reported on all outcomes by means of initial DBP strata.
Mean SBP/DBP was non significantly better in (C) versus (E).
Overall conclusion computer generated treatment (E) and usual care by physicians (C) was equivalent.
Allocation concealment B – Unclear
Study Cummings 1985
Methods Hypertensive patients attending in a single urban family practice
Participants Patients, aged 19 to 96, mean age 60. 62% female, 91% black, 11% newly diagnosed, 75% SBP <140mmHg
and DBP >90mmHg
Interventions (1) Appointment reminder- reminder card sent one week in advance of appointment and telephone patients
who missed appointments to schedule new ones(2) Usual care
Outcomes (1) Appointment keeping rate-appointments improved in (E- 87%) versus (C- 79%).(2) Dropouts from
treatment- drop outs less at 4 months in experimental group (E- 87/486, 18%) versus (C- 150/487, 31%)(3)
Blood pressure control- average SBP/DBP improved in experimental group(SBP-2mmHg, p=0.18 and DBP
-1mmHg, p=0.75)(4) Proportion of patients with controlled hypertension (<140/90)- 31% (E) versus 25%
(C)Duration FU 8 months
Notes
Allocation concealment B – Unclear
Study Dickinson 1981
Methods Factorial, Cluster, RCT
Participants Four clinical teams in Family Medicine Centre in USA, 4 faculty physicians37 residents. Each team received
on of the interventions.250 Patients, 69.9% female, mean age 49.6 years, 70.4% whitemean weight 78.9kg,
mean baseline BP 159/89mmHg. Inclusion criteria:(1) Hypertensive patients visiting practice during 4-
month baseline period(2) Elevated systolic or diastolic pressure at last baseline visit(3) At least one visit during
7-month intervention period
Interventions (1) Computer-generated feedback-monthly feedback reports on individual patients for physician, containing
identification, age, date of last visit and latest BP in those with uncontrolled hypertension (age 18-44
>/=140/90; 45-64 >/=150/95; age >64 >/=160/95) or overdue appointments
(2) Education programme- designed to increase physician awareness about non-compliance, plan long term
management based on periodic assessment, encourage family, behavioural and drug therapies. Three separate
self instructions
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(3) Both
(4) Neither
Outcomes 1) Follow up appointments increased in interventions-feedback 3.4, education 3.3, both 3.2, control 2.6
NS.(2) Knowledge-significantly improved in physicians who received education only, feedback 76, education
84, both 78, control 74(3) Blood pressure control- no difference - feedback 145/86mmHg, education
149/85mmHg, both 149/84mmHg, control 148/83(4) % with controlled hypertension- non significant
differences, feeback 65%, education 63%, both 57%, control 58%Duration of FU 7 months.
Notes Intervention randomised by, directed at physicians, analysis by patient No account taken of clustering.
Explains uneven patient numbers per arm of RCT
Allocation concealment B – Unclear
Study Earp 1982
Methods ParallelIndividuals
Participants Hypertension, taking BP medication that had been initiated, altered or re-started. Based in outpatient
hypertension clinic or family practice clinic
n=218, mean age 48, 59% female, 77% black
Interventions (1) Home visits- over 18 months by nurse or pharmacist. Provided a ”test of how effectively home-visit-
ing health practitioners could motivate and/or reinforce positive health behaviours, including medication
compliance“(2) Home visits plus involvement of ”significant other“- involved daily/several times a week BP
monitoring (3) Usual care
Outcomes (1) Home visit group versus usual care: proportion of patients in each group with uncontrolled hypertension
(DBP >/=95mmHg)- significant effect at year 2 (E) 21% versus (C) 42%, not significant at year 1 (E) 34%
versus (C) 34%.
(2) Home visit and involvement of significant other versus usual care; proportion of patients in each group
with uncontrolled hypertension (DBP 95mmHg)- non significant effect at year 2 (E) 25% versus (C) 42%,
not significant at year 1 (E) 39% versus (C) 34%.
Duration of FU: 1 year
Notes Large proportions lost to follow up at year 2, hence follow up at 1 year when pooling data.
Mean number of BP medication taken declined in the two intervention group (1.7 to 1.5 Group 1 and 1.5 to
1.4 Group 2) but increased in control group (Group 3 1.6 to 1.8); between group differences non significant.
Allocation concealment B – Unclear
Study Evans 1986
Methods Cluster- physicians stratified to solo or group practice and randomly allocated within strata
Participants Canadian family physicians. Eligible patients, age 30 to 69 years, either DBP >90mmHg at one home visit
and taking BP medication or no BP medication and DBP >90mmHg on 3 times at home visits
Interventions (1) Mailed CME to physicians14 weekly instalments of information, chart and fu appointment system to
encourage detection and recall of patients(2) Usual care
Outcomes (1) Blood pressure- (DBP<90mmHg, (E) 67% versus (C) 67%, non significant.(2) # visits for BP check-
no difference(3) # patients told BP elevated- no difference(4) # patients on BP medication- no difference(5)
Mean% compliance rate- no difference(6) % patients with controlled blood pressure- no differenceDuration
FU 1 year
Notes Cluster RCT- BP data aggregated at cluster level.
No difference found between intervention and usual care, 76% (E) and 79% (C) patients on BP medication.
Allocation concealment B – Unclear
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Study Fielding 1994
Methods Parallel, individuals at four work sites in the US
Participants Patients with increased blood pressure, either:
SBP140 and/orDBP90mmHg identifiedduringwork-site screening. 16%female, 30.5% takingBP lowering
durgs
Interventions (1) IMPACT consisted of monthly 10 minute individual sessions for patients with counsellor at work site
that included:
”Assessment of current behaviours
“Discussion re: treatment goals
”Compliance
“Mailed monthly package including personalised blood pressure information
”Incentives offered e.g. coupons for free sports equipment
“Sites were requested to offer at least six classes or demonstrations related to BP control during the year
(2) Usual care
Outcomes (1) Mean SBP/DBP changes-
SBP: significantly improved 138.1mmHg (E) versus 144.5mmHg (C)
DBP: -no difference 86mmHg (E) versus 86.5mmHg (C)
Adjusted difference:
SBP 7.6mmHg, p<0.05
DBP 2.4mmHg, NS
Duration of FU 1 year
Notes Statistically significant change for SBP (but notDBP) after adjustment for age, sex and baseline blood pressure
A significantly higher proportion of intervention group started BP lowering drugs (E) 13/49, 26.5% (C)
5/52, 9.6%
Allocation concealment B – Unclear
Study Fletcher 1975
Methods Parallel, individuals based in single emergency room in US
Participants Patients who attended emergency department with DBP 100mmHg and who had been given a follow up
appointment for a medical clinic
Interventions (1) Reminder (letter or phone) to attend follow up appointment at clinic, offer of assistance if problems
arose, followed up until attended clinic or missed two consecutive appointments
(2) Usual care
Outcomes (1) Returned to initial medical clinic appointment significantly improved 62/74 (E- 84%), 44/70 (C- 63%).
(2) Blood pressure control the same at FU 38/74 (E- 51%), 37/70 (C- 53%)
Duration of FU 5 months
Notes Improved initial attendance but blood pressure control in both groups the same. Process of care the more
vigorous in (E) group but (E- 38%), (C- 33%) said that they were on BP lowering drugs.
Blood pressure control defined in age-specific categories
20-39 <140/90
40-59 <150/95
>60 <160/100
Allocation concealment B – Unclear
Study Friedman 1996
Methods Parallel, individuals from 29 different communities, Boston, USA
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Participants Under care of physician for hypertension on BP lowering drugs, SBP >/=160 mmHg or DBP >/= 90mmHg
on average two readings. 90% white, 77% female, mean age 76 years
Interventions (1) Home monitoring and telecommunication system
”Weekly automated home blood pressure recording.
“Telephone-linked computer system (TLC)- computer-based telecommunications system that converses
with patients in their homes, patients contacted weekly. Provides advice concerning their blood pressure,
understanding of BP lowering medication, adherence to medication, symptoms that might relate to side
effects of therapy. Information directed to patient’s physician
(2) Usual care
Outcomes (1) Adherence to medication- improved by 18% (E) vs 12% (C), p=0.03.
(2) Mean change in SBP/DBP- no difference for SBP, (E) 158.5mmHg versus (C) 156.4mmHg, p=0.2;
significant difference for DBP, (E) 80.9mmHg versus (C) 83.2mmHg, p=0.02;
(3) Cost effectiveness- most cost effective for non-adherent patients
Duration of FU 6 months.
Notes Cost effectivenessmeasured all computer and telecommunication costs, facilities charges, supplies and support
personnel for start-up andmaintenance of the system.Cost effectiveness ratios were computed formedication
adherence improvement and DBP decrease using regression analysis
Allocation concealment B – Unclear
Study Garcia-Pena 2001
Methods Parallel, individuals, elderly ( 60) age-stratified sample recruited from 12 family medical centres, Mexico city,
Mexico
Participants Hypertension, mean SBP 160 or/both DBP 90 in untreated patients or treated hypertension patients Mean
BP level 161.9/90.8 (C) 162.1/90.9 (E) average age 70.6 years
Interventions (1) Nurse-based intervention
Nurses trained in aging and clinical aspects of hypertension including:
“Personal interviews
”Health behaviour change models
“Process of negotiation
”Ethical aspects of home visits
On each visit nurse did the following:
“Measured BP
”Discussed baseline health check and discussed lifestyle changes
“Guided patients in healthier lifestyle and negotiated specific targets
”Revised pharmacological treatment
“Adherence encouraged
Frequency of visits 2-4 weeks
(2) Usual care from insitute’s clinic and mailed pamphlet about hypertension
Outcomes (1) Blood pressure- mean change SBP 3.31 mmHg p=0.03, mean change DBP 3.67mmHg p<0.001
(2) Weight -1.1 kg significantly reduced
(3) Sodium excretion -5.8 ns
(4) Control BP <160/90mmHg improved 36.5% (E) versus 6.8% (C)
(5) Exercise- slow walking exercise increased (E) 9.1% versus decreased (C) 0.7%
(6) Not taking antihypertensive drugs (E) 15.9% versus (C) 26.9%
(7) Antihypertensive drug usage- increased in (E) change from baseline12.5% versus (C) 5.3%, difference
7.2% p=0.02
Duration of FU 6 months
Notes Well conducted RCT. Nurse intervention aimed at both pharmacological and non-pharmacological man-
agement of hypertension. Had positive effect on mean SBP/DBP and BP control with increases in number
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taking antihypertensive medications. Non pharmacological treatment also effective at reducing weight, in-
creasing exercise with non significant reduction in sodium excretion
Allocation concealment A – Adequate
Study Gullion 1987
Methods Factorial RCT, randomised by physician (n=111), analysed by patient (n=2583), San Francisco USA. Average
of 23 patients per practice
Participants Hypertensive patients using anti-hypertensive medication, had a DBP >90mmHg at some stage of their care.
Age range 20-80 years
Interventions (1) Medical education-
”Individualised feedback on medical record information, detailed peer-review
“Syllabus material
”Educational session by means of telephone call with faculty expert discussing feedback reports and syllabus
materials.
(2) Behavioural education-
“Individualised feedback on patient survey summaries, detailed peer-review
”Syllabus material
“Educational session, telephone call with faculty expert discussing feedback reports and syllabus materials
(3) Both interventions
(4) Neither intervention
Outcomes (1) DBP- no difference between four groups either for mean DBP (85.17, 85.59, 85.16, 85.79 mmHg
respectively) or for % with controlled DBP (68.65%, 66.78%, 67.93%, 68.25% respectively) at follow up.
(2) Lifestyle outcomes- no difference apart from decreased BMI in behavioural group.
(3) Health promotion advice given- more likely to be given advice re: medication regimen, side effects of
drugs, sodium intake in behavioural group.
Duration of FU 1 year
Notes Negative RCT with regard to primary outcome of DBP.
Caution required with interpretation of lifestyle and health promotion outcomes. Multiple comparisons.
DBP reported but not usable because no baseline numbers randomised reported or standard deviations
Allocation concealment B – Unclear
Study Hamilton 1993
Methods Parallel, individuals based in hypertension clinic in tertiary care teaching medical centre, US
Participants Thirty four treated hypertensives DBP 90mmHg and/or SBP 160 mmHg, participating in therapeutic
hypertension regimen. Mean age 54 years, white, married, high school educated.
Interventions (1) Postcard reminder one week before the next regularly scheduled appointment, a 30 to 40 min interven-
tion with the nurse practitioner before the appointment with the physician (including tailored care plan,
information on hypertension, discussion of risk factors, max. 45 min total time), follow up phone call one
month after the intervention to evaluate the negotiated plan of care.
(2) Usual care- no self recording
Outcomes (1) SBP/DBP- improved SBP difference -17.3 mmHg, not DBP -4.7 mmHg, (p=0.03 and 0.22 respectively)
(2) Compliance (self report)- no difference, adherence score of 27.5 in intervention group vs 24.5 in control
group (p=0.12)
(3) Mean number of appointments kept- improved 97% (E) v 74% (C) (p=0.04)
(4) Physician rated patient adherence- improved (E), adherence score of 29.18in intervention group vs 23.92
in control group (p=0.005)
Duration of FU 6 months
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Notes SBP improved, mean number of appointments kept improved in (E) group, adherence no difference on self-
report
Small RCT
Allocation concealment B – Unclear
Study Hawkins 1979
Methods Parallel
Individuals
Participants Medical OPD clinic, San Antonio, US, patients fu for hypertension (42% E) (49% C) and diabetes or both
(28% E) (21% C), mean age 61 (E) 60 (C), >90% Mexican Americans, (female 76% E, 78% C)
Interventions (1) Clinical pharmacist- chronic disease management in OPD setting (medical care monitored by family
practice faculty)
(2) Usual care by physician
Outcomes (1) Kept-clinic appointments
(2) Compliance withmedication (prescription record)- improved diuretic only: 60.5% adherent (E) vs 52.9%
(C) (p<0.7), diuretic plus methyldopa: 84.6 % (E) vs 65.4% (C) (p=0.2)
(3) Kept OPD appointments- 83.3% (E) vs 73.8% (C) (p<0.0005)
(4) Frequency of clinic visit- 6.69 (E) vs 5.38 (C) (p=<0.001)
(4) Mean SBP (E) 147mmHg versus 141 (C); p<0.01. Mean DBP 84mHg (E) versus 84mHg (C) non
significant.
Duration FU 24-29 months
Notes Improved for pharmacist led care(E) for:
(1) Kept OPD appointments
(2) Frequency of OPD appointments
(3) Mean SBP between group comparison- improved in (E) group but worse for DBP
Allocation concealment B – Unclear
Study Haynes 1976
Methods Parallel
Individuals
Participants Hypertensive males (n=39), not compliant (pill counts <80%) or at goal DBP ( 90mmHg) after 6 months
(previously enrolled in a separate RCT, see Sackett 1975)
Interventions (1) Patient self monitoring and education, includes:
”Home self-measurement of BP
“Home BP and medication charting
”Tailoring- patients interviewed to improved medication taking
“Increased supervision and reinforcement- fortnightly review including positive re-enforcement.
All interventions supervised and executed by non health professional programme coordinator
(2) Usual care
Outcomes (1) Compliance- increased in experimental group (E) 65.8 versus (C) 43.2, p=0.025
(2) Control of DBP- increased in experimental group, (E) 93.1mmHg versus (C) 96.4mmHg, p=0.12
(3) Combined compliance and DBP targets- increased in experimental group
Duration of FU 1 year.
Notes (1) No data given- change in DBP and compliance reported
(2) Experimental group patients received significantly more attention than control patients (5 hours over 6
months)
(3) Physicians treating experimental patients prescribed more vigorously
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Allocation concealment B – Unclear
Study Hetlevik 1998
Methods Cluster (29 health centres, 53 family practitioners), analysed by patient (2239 patients). Two regions in
Norway.
Participants Hypertensive patients (baseline BP level given), mean age 64 years, 57% female.
Interventions (1) Computer based decision support system (CDSS). Doctors and assistants trained and received a user
manual. Re-enforcement by means of telephone repetitions seminar on risk intervention and further demon-
stration of CDSS.
(2) Usual care
Outcomes (1) SBP/DBP- SBP no difference (E) 156.8mmHg versus (C) 155.6mmHg NS, DBP (E) 88.8mmHg versus
89.8mmHg, p<0.05(2) Cholesterol(3) % smokers(4) BMI(5) Coronary heart disease risk score.All other
outcomes no different between groups(6) Recording of risk factor data- improved slightly in (E) group for
cholesterol and family history.Duration of FU 24 months.
Notes Only 104 (11%) patients had CDSS used on them during trial period.
Allocation concealment B – Unclear
Study Hetlevik 1999
Methods Cluster (29 health centres, 53 family practitioners), analysed by patient (2239 patients). Two regions in
Norway.
Participants Hypertensive patients (baseline BP level given), mean age 64 years, 57% female.
Interventions (1) Computer based decision support system (CDSS). Doctors and assistants trained and received a user
manuel. Re-enforcement by means of telephone repetitions seminar on risk intervention and further demon-
stration of CDSS.(2) Usual care
Outcomes (1) SBP/DBP- SBP (E) 156.8mmHg versus (C) 155.6mmHg NS, DBP (E) 88.8mmHg versus 89.8mmHg,
p<0.05
(2) Cholesterol
(3) % smokers
(4) BMI
(5) Coronary heart disease risk score.
All other outcomes no different between groups
(6) Recording of risk factor data- improved slightly in (E) group for cholesterol and family history.
Duration of FU 24 months.
Notes Only 104 (11%) patients had CDSS used on them during trial period.
No account for clustering reported in the analysis section
Allocation concealment B – Unclear
Study Hypertension 1979
Methods Patients identified at 14 “HDFP centres throughout the US (13 by residential area- census tract, probability
sample of larger areas, entire housing projects or in one centre by employment roll of industries). Randomi-
sation at the patient level after initial screening. Initially screened for DBP, 2 stage process:(1) All 158,096
screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for second screen at clinic,
regardless of whether taking BP lowering drugs or not. (2) If mean DBP 90mmHg, patient eligible and
randomised. 10,940 agreed to randomisation Randomisation stratified according to entry DBP and HDFP
centre:(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)(3)
Stratum iii- 115 mmHg, n=1,063 (9.7%)No SBP entry criteria and no upper limits of BP11,386 persons
randomised but 446 subsequently excluded due to randomisation error that occurred at one clinic
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Participants Inclusion criteria:(1) Men and women age 30 to 69 years(2) Average home screening DBP 95mmHg(3)
Confirmed follow up DBP 90mmHgExclusion criteria:(1) Terminally ill(2) Institutionalised 10,940 ran-
domised, 54% male, 45% blackAntihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment by means
of:
”Free care- visits, drugs, investigations, transport
“Emphasis placed on clinic attendance and compliance- pill counts used
”Convenience- low waiting times, parmedical personnel, physician on call
“Stepped drug treatment according to BP response
”Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every 2
months
(2) Referred care (RC): referred to their “primary sources of care, usually own physicians.
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BPmeasurement
and at the clinic at years 2 and 5 for an examination. At each contact each RC participant was advised to
visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special steps were taken to
achieve contact with a physician.
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step 2,
9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihypertensive
therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg.
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Allocation concealment A – Adequate
Study Hypertension 1979a
Methods Patients identified at 14 “HDFP centres throughout the US (13 by residential area- census tract, probability
sample of larger areas, entire housing projects or in one centre by employment roll of industries). Randomi-
sation at the patient level after initial screening. Initially screened for DBP, 2 stage process:
(1) All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for second
screen at clinic, regardless of whether taking BP lowering drugs or not.
(2) IfmeanDBP90mmHg, patient eligible and randomised. 10,940 agreed to randomisationRandomisation
stratified according to entry DBP and HDFP centre:
(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)
(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)
(3) Stratum iii- 115 mmHg, n=1,063 (9.7%)
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No SBP entry criteria and no upper limits of BP
11,386 persons randomised but 446 subsequently excluded due to randomisation error that occurred at one
clinic
Participants Inclusion criteria:
(1) Men and women age 30 to 69 years
(2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg
Exclusion criteria:
(1) Terminally ill
(2) Institutionalised
10,940 randomised, 54% male, 45% black
Antihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment by means
of:
”Free care- visits, drugs, investigations, transport
“Emphasis placed on clinic attendance and compliance- pill counts used
”Convenience- low waiting times, parmedical personnel, physician on call
“Stepped drug treatment according to BP response
”Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every 2
months
(2) Referred care (RC): referred to their “primary sources of care, usually own physicians.
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BPmeasurement
and at the clinic at years 2 and 5 for an examination. At each contact each RC participant was advised to
visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special steps were taken to
achieve contact with a physician.
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step 2,
9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihypertensive
therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg.
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Allocation concealment A – Adequate
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Study Hypertension 1982
Methods Patients identified at 14 “HDFP centres throughout the US (13 by residential area- census tract, probability
sample of larger areas, entire housing projects or in one centre by employment roll of industries). Randomi-
sation at the patient level after initial screening. Initially screened for DBP, 2 stage process:
(1) All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for second
screen at clinic, regardless of whether taking BP lowering drugs or not.
(2) IfmeanDBP90mmHg, patient eligible and randomised. 10,940 agreed to randomisationRandomisation
stratified according to entry DBP and HDFP centre:
(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)
(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)
(3) Stratum iii- 115 mmHg, n=1,063 (9.7%)
No SBP entry criteria and no upper limits of BP
11,386 persons randomised but 446 subsequently excluded due to randomisation error that occurred at one
clinic
Participants Inclusion criteria:
(1) Men and women age 30 to 69 years
(2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg
Exclusion criteria:
(1) Terminally ill
(2) Institutionalised
10,940 randomised, 54% male, 45% black
Antihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment by means
of:
”Free care- visits, drugs, investigations, transport
“Emphasis placed on clinic attendance and compliance- pill counts used
”Convenience- low waiting times, parmedical personnel, physician on call
“Stepped drug treatment according to BP response
”Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every 2
months
(2) Referred care (RC): referred to their “primary sources of care, usually own physicians.
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BPmeasurement
and at the clinic at years 2 and 5 for an examination. At each contact each RC participant was advised to
visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special steps were taken to
achieve contact with a physician.
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
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Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step 2,
9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihypertensive
therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg.
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Allocation concealment A – Adequate
Study Hypertension 1986
Methods Patients identified at 14 “HDFP centres throughout the US (13 by residential area- census tract, probability
sample of larger areas, entire housing projects or in one centre by employment roll of industries). Randomi-
sation at the patient level after initial screening. Initially screened for DBP, 2 stage process:
(1) All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for second
screen at clinic, regardless of whether taking BP lowering drugs or not.
(2) IfmeanDBP90mmHg, patient eligible and randomised. 10,940 agreed to randomisationRandomisation
stratified according to entry DBP and HDFP centre:
(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)
(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)
(3) Stratum iii- 115 mmHg, n=1,063 (9.7%)
No SBP entry criteria and no upper limits of BP
11,386 persons randomised but 446 subsequently excluded due to randomisation error that occurred at one
clinic
Participants Inclusion criteria:
(1) Men and women age 30 to 69 years
(2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg
Exclusion criteria:
(1) Terminally ill
(2) Institutionalised
10,940 randomised, 54% male, 45% black
Antihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment by means
of:
”Free care- visits, drugs, investigations, transport
“Emphasis placed on clinic attendance and compliance- pill counts used
”Convenience- low waiting times, parmedical personnel, physician on call
“Stepped drug treatment according to BP response
”Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every 2
months
(2) Referred care (RC): referred to their “primary sources of care, usually own physicians.
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BPmeasurement
and at the clinic at years 2 and 5 for an examination. At each contact each RC participant was advised to
visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special steps were taken to
achieve contact with a physician.
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
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(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step 2,
9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihypertensive
therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg.
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Allocation concealment A – Adequate
Study Jewell 1988
Methods Hypertensive patients in a single practice in the UK
Participants Patients aged 30-64 years.
Newly diagnosed: raised DBP >100mmHg aged 30-39, >105mmHg aged >40
Previously diagnosed: DBP >95mmHg on 3 measurements at a single visit
Interventions (1) Nurse-led clinic. Agreed protocol determined treatment and frequency of attendance in both groups.
Target was to reduce DBP <90mmHg, 15 minute consultation.
Note: both nurse led and doctor led care was by means of identical protocol.
(2) Usual care-general practitioner 10 minute consultation
Outcomes (1)Mean SBP/DBP- between group difference inmean SBP -0.8mmHg (-8.7 to 24.7) NS,DBP - 0.4mmHg
(-6.2 to 7) NS.
(2) Proportion with DBP <90mmHg
10/15 (E- 67%)
12/19 (C- 63%)
(3) Quality of data recording (better in nurse group for pulse, weight, urine testing)
(4) Frequency of attendance (no difference, mean annual rates 5.7 (C)
6 (E) groups.
(5) Knowledge of medication (no difference)
(6) Reactions to the service (no difference)
Duration FU 1 year
Notes
Allocation concealment B – Unclear
Study Johnson 1978
Methods Factorial RCT,
randomised at individual level, stratified by age and sex.
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Participants Screenees from a Canadian shopping centre, n=140 (male 82), age 35-65 years
All taking BP lowering medication for 1 year with uncontrolled hypertension (DBP 95mmHg)
Interventions (1) Self recording- given BP recording device, take BP daily and take charts with BP records to their physician
(2) Home visits- BP measured in their homes every 4 weeks with result given to them and physician.
Both groups visited at home after 2 weeks
(3) Both interventions
(4) Neither intervention
Outcomes (1) Changes in mean DBP- no difference
(2) Changes in mean compliance- no difference.
(3) Changes mean compliance in those with initial compliance <80%- no difference
(4) Change mean DBP in those with initial problems remembering to take BP medication- subgroup effect
in initially difficult to remember group
(5) Change in strength in therapy- no difference
Duration of FU 6 months
Notes More ”explanatory“ RCT, follow on fromHaynes. In contrast to positive findings in Haynes RCT, this RCT
proved to be negative. Main difference in this RCT is that home visitors dealt with only measurement of BP,
no attempts made to influence medication taking. No standardised treatment regimen or goal BP advocated
to treating physicians
Allocation concealment B – Unclear
Study Krieger 1999
Methods Parallel, individuals in a single ”low income“ area of Seattle, USA
Participants Hypertensive patients (entry SBP 140mmHg or DBP 90mmHg). 4761 had BP measured, 759 (15.9%)
eligible, 421 (55.5%) participated. Overall, 40% taking BP lowering medication, 79% black, 66% below
federal poverty level, 33% BP 160/100mmHg. All participants paid $25 for completing study
Interventions (1) Outreach and tracking by community health worker. Provided: referral to medical care and assistance
with finding a provider; ensure appointment with health worker; appointment reminder letter; follow up
patient (up to 3 times) to see if appointment kept; new appointment if one missed (up to 3 times); assistance
to reduce barriers to care including transport, child care or other services
(2) Usual care
Outcomes (1) Follow up appointment within 90 days- (E) 95/146 (65.1%) versus (C) 77/165 (46.7%).
(2) SBP/DBP-improved SBP (E) 139.4mmHg versus (C) 141mmHg, DBP no difference (E) 84.6mmHg
versus (C) 84.3mmHg
Duration of FU 3 months.
Notes Study designed to assess follow up within 30 days. Large differential loss to follow up (greater in intervention
arm).
Mean SBP/DBP data provided by authors of study
No intention to treat analysis.
Allocation concealment B – Unclear
Study Levine 1979
Methods Factorial trial with 8 groups of various combinations of the 3 interventions and control individuals at two
hypertension clinics in US
Participants 91% black, median age 54 years, 70% female, low income ($45250 median yearly income).
BP (mmHg) entry criteria based on age:
20-39: >140/90
40-59: >150/95
60: 160/100
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Interventions (1) Three interventions:
”Exit interview- individualised 5-10 minute counselling session, explaining and re-inforcing instructions to
the patient
“Instructional session with adult at home concerning adherence and follow up care
”Group sessions- three, one hour sessions led by social worker
“Seven experimental groups and one control group
(2) Usual care with none of above interventions
Outcomes (1) Deviation in weight from ideal weight- significantly better in patients who received all 3 interventions
compared to those who received none
(2) Appointment keeping (ratio of kept/scheduled)- improved in group who received all 3 interventions
versus control at 2 yrs (E) .68 versus (C) .63; no difference at 5 yrs (E) .95 versus (C) .83
(3) Adherence to drug therapy- all improved, greatest in 3 intervention arm versus control (53% vs 40%)
(4) % patients with controlled BP - increased at 2 years (E) 52% versus (C) 42%; 5 years (E) 66% versus
(C) 56%. Significantly better in four intervention groups compared to control at 5 years
(5) All cause mortality- cumulative mortality better in all experimental groups combined (12.9) compared
to control group (30.2)
(6) Cost effectiveness- multiple interventions appear more effective, not necessarily more cost effective.
Authors feel thatmay be better to use single interventions depending on setting and financial constraints{821}
Duration of FU 2 and 5 years.
Notes Multiple comparisons in results section: 7 intervention arms and one control group
In addition no a priori sub-group analysis
Blood pressure control age-specific categories
<40 <140/90,
40-59 <150/95
60, <160/100
Substantially greater numbers lost to follow up in (C) arm at 2 and 5 years
Allocation concealment D – Not used
Study Logan 1979
Methods Parallel
Individuals
Participants Volunteers from business settings with newly diagnosed hypertension (DBP 95mmHg, orDBP 91-94mmHg
and SBP >140mmHg)
Interventions (1) Work-site care- nurse management according to a standard protocol- including drug regimen and regular
review, once monthly if BP not controlled
(2) Usual care from their own family physicians
Outcomes (1) # patients taking BP treatment- increased in Experimental group (177/206, 86% vs 108/204, 53%)
(2) Mean DBP- improved in (E) 94.3mmHg versus (C) 90.3mmHg, p<0.01.
(3) Reach goal DBP- 50% (E) versus 28.9% (C).
(4) Compliance-better in experimental group (67.6% vs 49.1%)
Duration of FU 6 months
Notes Goal DBP <90mmHg if entry DBP >95mmHg; or <6mmHg in those with entry DBP 95mmHg or less.
Allocation concealment B – Unclear
Study Martinez-Amenos 1990
Methods Parallel
Individuals
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Participants Hypertension Registry from 19 primary care centres in Spain. Mean age 61 years, 59% female
Initial volunteers asked if theywished to participate; those agreeingwere randomised and labelled ”motivated“
group; group who declined to participate also followed up ”non motivated“
Interventions (1) Individual education- comments and explanations to errors encountered in answers to baseline knowledge
questionnaire
(2) Team education- 2 talks given by nurses or doctors with AV material to 8-12 patients
(3) Control group
Outcomes (1) Proportion of patients in each group with uncontrolled hypertension (SBP <160, DBP <95mmHg)-
within group increase reported for both intervention arms, individual 50.4% to 60.9%, team, 55.8% to
68.8%, non significant within group change in control group, 54.4% to 58.9%
(2) Patient knowledge- no between group difference, individual 19.79, Team 20.58, control 19.78
Duration of FU: 2 months
Notes Knowledge increased within all 3 groups over time, between group comparison not statistically tested
No baseline numbers per arm of study reported
% control BP not included in meta-analysis as no denominator data available at start of RCT
Allocation concealment B – Unclear
Study McAlister 1986
Methods Cluster (60 doctors initially, 10 dropped out), parallel, Toronto Canada
Participants N=50 general practitioners, 1241 (E) 990 (C), hypertensive patients with one of the following:
(1) DBP >90 mmHg on treatment
(2) DBP >104 mmHg not on treatment
(3) DBP >90 or <105 mmHg unless evidence of complications or risk factors
(4) Newly detected patients with “high blood pressure” detected during the trial
Interventions (1) Computer generated feedback to physician:
“Cumulative chart of patient’s DBP
”Inter and Intra practice DBP ranking
“Commentary on treatment by GP according to a ”stepped care“ approach
(2) Control group filled out same forms but no feedback given
Outcomes 1)Workload: GPs in experimental group saw more patients
(2) Mean score on length of follow up: better in intervention 199.3 days (E) vs 167days (C)
(3) Drop outs: 37.5% (E) vs 42.1% (C)
(4) In all patients DBP reading in those with initial DBP > 104mmHg: 88.5mmHg (E) vs 93.3mmHg (C),
net DBP change 0.8mmHg P <0.1
(5) % patients with controlled DBP ( 90mmHg)- 88.9% (E) versus 87.5% (C) NS
(6) # days with sustained DBP control 323 (E) vs 259(C)
(7) # times visited GP: 13.3 (E) vs (17.4)
Duration 16 months
Notes Multiple outcomes reported, some favourable for experimental arm- saw more patients who were less likely
to drop out of care. Doesn’t appear to have had an impact on overall DBP control but other measures of BP
control favoured intervention group such as number of days with sustained DBP control. This was achieved
with fewer visits in the intervention group
Allocation concealment B – Unclear
Study Mehos 2000
Methods Parallel, individuals in a single family medicine clinic, US
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Participants 41 uncontrolled hypertensives, SBP 140-179mmHg and/or DBP 90-109mmHg, currently on treatment,
mean age 59 years, 70% women
Interventions (1) Home blood pressure monitoring, diary and instruction to measure blood pressure, information on
hypertension and risk factors, subsequent evaluation by clinical pharmacist (2) Usual care
Outcomes (1) SBP, DBP and mean BP- all reduced in (E) group, SBP (E) 140.8mmHg versus (C) 146.9mmHg
(p=0.069), DBP (E) 80.6mmHg versus (C) 85.6mmHg (p=0.02),
(2) Compliance (self report)- mean adherence 82% (E) vs 89% (C) (p=0.29)
(3) Drug alteration (dosage increase, addition or switch)- 83% (E) vs 33% (C) (p=0.29)
(4) Quality of life (SF36)- no difference between groups
Duration of FU 6 months
Notes
Allocation concealment B – Unclear
Study Midanik 1991
Methods Parallel, individuals, from a single foundation health plan in California, US.
Participants 204 untreated hypertensive patients with ”mild“ hypertension- SBP <180mmHg and DBP 90-99mmHg
Interventions (1) Self monitoring- patients trained to take two consecutive readings twice a week. Sent in readings every 4
weeks for one year(2) Usual care
Outcomes (1) Blood pressure- mean change SBP -1 mmHg, mean change DBP -1 mmHg (E) versus mean change SBP
+1 mmHg, mean change DBP -1 mmHgDuration of FU 1 year
Notes Untreated subjects with 18% of (E) and 17% of (C) patients taking antihypertensive medication at the end
of the RCT
Allocation concealment B – Unclear
Study Montgomery 2000
Methods 27 general practice in UK, Cluster RCT, patients on register
Participants Hypertensive patients aged 60-80 taking BP lowering drugs.
Randomly selected from practice register
Interventions (1) Computer based decision support system (CDSS)
(2) Risk chart
Both interventions provided health professional (general practitioner or practice nurse) with explicit cardio-
vascular risk. Based on New Zealand hypertension guidelines.
(3) Usual care
Outcomes (1) Cardiovascular risk- no change in CVD risk between 3 groups
(2) SBP/DBP- adjusted analysis, chart group had better mean SBP reading than usual care (difference
4.6mmHg)
(3) Proportion of patients with controlled hypertension (<160/90)- no difference between two intervention
groups chart 39.7%, CDSS 47.5% and control 40.7%
(4) Medication change- intensity of BP medication prescribing greater in chart group compared to usual care
Duration of FU 1 year
Notes
Allocation concealment A – Adequate
Study Morisky 1983
Methods Factorial trial with 8 groups of various combinations of the 3 interventions and control individuals at two
hypertension clinics in US
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Participants 91% black, median age 54 years, 70% female, low income ($45250 median yearly income).
BP (mmHg) entry criteria based on age:
20-39: >140/90
40-59: >150/95
60: 160/100
Interventions (1) Three interventions:
”Exit interview- individualised 5-10 minute counselling session, explaining and re-inforcing instructions to
the patient
“Instructional session with adult at home concerning adherence and follow up care
”Group sessions- three, one hour sessions led by social worker
“Seven experimental groups and one control group
(2) Usual care with none of above interventions
Outcomes (1) Deviation in weight from ideal weight- significantly better in patients who received all 3 interventions
compared to those who received none
(2) Appointment keeping (ratio of kept/scheduled)- improved in group who received all 3 interventions
versus control at 2 yrs (E) .68 versus (C) .63; no difference at 5 yrs (E) .95 versus (C) .83
(3) Adherence to drug therapy- all improved, greatest in 3 intervention arm versus control (53% vs 40%)
(4) % patients with controlled BP - increased at 2 years (E) 52% versus (C) 42%; 5 years (E) 66% versus
(C) 56%. Significantly better in four intervention groups compared to control at 5 years
(5) All cause mortality- cumulative mortality better in all experimental groups combined (12.9) compared
to control group (30.2)
(6) Cost effectiveness- multiple interventions appear more effective, not necessarily more cost effective.
Authors feel thatmay be better to use single interventions depending on setting and financial constraints{821}
Duration of FU 2 and 5 years.
Notes Multiple comparisons in results section: 7 intervention arms and one control group
In addition no a priori sub-group analysis
Blood pressure control age-specific categories
<40 <140/90,
40-59 <150/95
60, <160/100
Substantially greater numbers lost to follow up in (C) arm at 2 and 5 years
Allocation concealment B – Unclear
Study Muhlhauser 1993
Methods 10 general practices Germany, 20 hypertensive patients randomly selected (age 30-60 years)
Participants Hypertension (mean last 2 measurements 160 and/or 95). Taking BP medication (E 77%, C 86%)
Interventions (1) Hypertension treatment and teaching programme (HTTP) consisted of:
“Four consecutive meetings lasting 60-90 mins in groups of 4-6.
”Provided by physician assistants
“Responsibility including BP self monitoring
”Confirming diagnosis and treatment by using home BP measurements
“Emphasis on non-pharmacological treatment
Doctors (8 hours) and assistants (20 hours) in intervention practices attended preparatory course but RCT
aimed principally at patients
(2) Usual care
Outcomes (1) Change in SBP/DBP- significantly improved at follow up, difference SBP 5mmHg, DBP 4mmHg
(2) Proportion of patients with controlled hypertension (<140/90)- no difference (E) 14% versus 15% (C)
(3) # BP drugs taken
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Duration of FU 18 months
Notes (1) Only 46 (46%) in intervention group received intervention (2) Cluster RCT not accounted for design
or analysis.
(3) Well conducted RCT but differential losses to FU
(4) Less people in intervention group taking BP medication at end of RCT (mean # (E)- 1.2, (C) 1.8)
Allocation concealment B – Unclear
Study New 2004
Methods Cluster RCTGeneral practices
Participants 44 general practices, Salford, UK, 10303 participants
Interventions (1) Educational outreach: specialist nurses arranged a schedule of visits with general practitioners and practice
nurses, reminding them of protocols and clinical targets; provided educational material and protocols used in
secondary care for nurse and doctor interventions including stepping up pharmacotherapywhen necessary.(2)
usual care
Outcomes (1) Proportion of participants reaching blood pressure target/OR: no difference between groups OR 1.01
(95% CI 0.8 to 1.3, p=0.93).
Notes Study funded by pharmaceutical company.
Allocation concealment B – Unclear
Study Ornstein 2004
Methods Cluster RCT, 20 community-based family or general internal medicine practices in 14 US states. 44 physi-
cians, 17 “midlevel” providers and approximately 200 staff members
Participants Of 87,291 patients from 20 practices, 7772 (8.9%) with hypertension. At baseline 40% (E) and 43.7% (C)
had “controlled” blood pressure (<140/90).
21 study indicators included:
-Hypertension (5) including most recent BP measurement <140/90 for patients with a diagnosis of hyper-
tension
-Hyperlipidemia (2)
-Coronary heart disease (6)
“Heart failure (1)
-Atrial fibrillation (1)
-Diabetes (6)
Interventions (1) Multi-method quality improvement (QI)-
-Practice site visits (6-7, 1-2 day site visits in a two year period) involving physicians and pharmacist with
expertise in academic detailing. Healthcare providers encouraged to use (QI) tools
-Two-day network meetings in each study year. Initial meeting directed at lead clinician with ”best practice“
presentations made by participating clinicians who were performing well. Clinical and administrative staff
attended second meeting
(2) Usual care- received copies of practice guidelines and quarterly performance reports
Outcomes (1) Control BP <140/90mmHg improved 58.4% (E) versus 51.9% (C), adjusted difference 8.0 (0.0 to 16.0),
p=0.047
Duration of FU 2 years
Notes Generalmulti-method across 6 conditions and 21 quality indicators. Overall intervention practices improved
22.4 percentage points in terms of indicators at or above target, compared to 16.4 in control practices,
difference 6.0 percentage points (p>0.2).
Patients in intervention practices had greater improvements than control practices for diagnosis of hyperten-
sion and blood pressure control
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Allocation concealment B – Unclear
Study Park 1996
Methods Parallel, individuals two pharmacies, US
Participants Taking BP lowering treatment or had BP 140/90 mmHg. mainly white treated hypertensives, 50% women,
mean age 60 years
Interventions (1) Pharmacist administered monthly patient management including education, medication changes, verbal
counselling and written information on hypertension and risk factors
(2) Traditional pharmacy services
Outcomes (1) SBP/DBP- improved SBP (E) 143.2mmHg versus (C) 148.6mmHg, DBP (E) 83.2mmHg versus (C)
83.7mmHg, no between group p values reported
(2) Control of blood pressure (<140/90 mmHg)- improved 52.2% (E) vs 17.4% (C), p<0.02
(3) Compliance (pill counts, unaware)- mean adherence 86.8% (E) vs 89.1% (C) no p value reported
(4) Self reported quality of life- in general higher in (E) vs (C) group
(5) Time spent with patient- higher in (E) group, particularly at first visit
Duration of FU 4 months
Notes
Allocation concealment B – Unclear
Study Pierce 1984
Methods Factorial, individuals, single general practice clinic, Western Australia
Participants Uncontrolled hypertensives (SBP 160 and/or DBP 95) taking BP medication, mean age 57 years, 60%
women,
Interventions (1) Self monitoring of blood pressure: 30 min briefing, monthly recording chart
(2) Health education programme promoting a healthy cardiovascular lifestyle: four meetings, 90 min dura-
tion, max 12 participants, encouraged to make action goals, information (risk factors for heart disease, stress,
diet)
(3) Both interventions
(4) Usual care
Outcomes (1) Blood pressure control- Education: 83% (E) vs 67% (C) (p<0.05, effect size unclear) p<0.05Monitoring:
74% (E) vs 78% (C) NS
(2) Compliance (pill count, self report)- No significant difference between groups: Education: 27% good
adherers versus 24% in control group.
Monitoring: 30% Both interventions: 26%
(3) Patient Knowledge- no difference
Duration of FU 12 months
Notes Health education appears more beneficial in controlled blood pressure than self monitoring.
Blood pressure reduction, target blood pressure level not defined
Allocation concealment B – Unclear
Study Robson 1989
Methods Parallel, individuals based in a single family practice in UK
Participants Patients registered in the practice. Age 30-64. Also concerned with recording and follow up of other cardio-
vascular risk factor data and cervical screening follow up
Interventions (1) Recording and follow up of blood pressure and other cardiovascular risk factors with practice nurse or
general practitioner aided by computer
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(2) Usual general practitioners follow up
Outcomes (1) Blood pressure recording in all patients- increased 1511/1620 (E- 93%) 1160/1586 (C- 73%)
(2) Blood pressure recording in hypertensive patients- increased 104/107 (E- 97%) 90/116 (C- 69%)
(3) Other cardiovascular risk factors- all increased recording in intervention group, smoking, family history
and cholesterol
Duration of FU 2 years
Notes Improved recording of blood pressure and other cardiovascular risk factors
Allocation concealment B – Unclear
Study Roca-Cusachs 1991
Methods Parallel, individual in a hypertension clinic, Spain
Participants Newly diagnosed hypertensive patients (excluded age >70, illiterate and “high probability of non attendance”)
Entry SBP/DBP noted but no threshold required for eligibility. Mean values were:
(E) 156.3/95.8
(C) 160.3/96.1
Interventions (1)Patient education-
“Booklet at initial entry into study
”Two educational talks. First educational talk given by pharmacist and doctor, covered information about
hypertension, treatment adherence and appointments; second educational talk given by dieticians covered
non-pharmacological treatments.
“Personal tutorial meeting one month later- solve problems, clarify misunderstandings and re-enforce knowl-
edge.
(2) Usual care
Outcomes (1) Weight- no difference
(2) Mean SBP/DBP- no difference
(3) Withdrawals- 39% (E) vs 26% (C) significant difference
(4) Knowledge questionnaire- improved knowledge in (E) group
(5) Number of BP pills taken- no difference
(6) Biochemical markers- no difference
Duration of FU 6 months
Notes (1) Knowledge improved, other outcomes no difference, withdrawal from the programme greater in the (E)
39% versus (C) 25%
(2) Large proportion of (E) failed to attend an educational session, 83/138 (60%).
(3) Sub-group analysis showed that 55/138 (40%) who attended one or more educational session did not
have a different outcome in terms of all outcome measures at follow up, including SBP/DBP than those
in intervention group who failed to attend sessions 83/138 (60%), except that those who attended had
significantly higher probability of not withdrawing overall 3.6% vs 63%.
Allocation concealment D – Not used
Study Rogers 2001
Methods Medical outpatients department, patients covered by insurance under care of 5 internists, New York state,
US.
Participants Previous diagnosis of hypertension but were being considered for change in BP medication because:
(1) SBP 140 or DBP 90 despite current antihypertensive therapy
(2) Side effects from drugs
(3) SBP >180 or DBP >110 without current antihypertensive therapy
Interventions (1) Telecommunication service with 3 components:
“Automated BP at home with no self report
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Characteristics of included studies (Continued )
”Central processing of BP readings
“Weekly reports to both physician andpatient.Whenphysicians received report forms that indicated increased
blood pressure they adjusted BP medication via telephone call, office visit or both. Readings minimum of 3
days each week for minimum 8 weeks
(2) Usual care
Outcomes (1) Mean change in arterial blood pressure- improved -2.8mmHg (E) versus +1.3 (C) p=0.013
(2) Mean change in systolic blood pressure- improved -4.9mmHg (E) versus -0.1 (C) p=0.047
(3) Mean change in diastolic blood pressure- improved -2mmHg (E) versus +2.1 (C) p=0.012
Median duration of FU 11 weeks
Notes Change in mean arterial BP primary outcome via 24 hr ambulatory reading
Change in BP medication related to change in mean arterial BP and was more common in intervention
group, 33% (E) versus 7% (C) group.
No change in median number of office visits
Difference in median length of FU (longer in intervention group, 79 vs 72 days)
Satisfaction with care same in both groups
Allocation concealment A – Adequate
Study Rudd 2004
Methods Parallel RCT, two medical clinics
Participants Hypertension- SBP ?140 mmHg or DBP ?90mmHg in previous six months or history of drug treatment.
Drug therapy for patients with 150 mmHg or DBP 95 mmHg.
Interventions (1) Self measurement with nurse management based on algorithm. Twice daily measurement, after 14 mea-
surements mailed to nurse care manager who used this BP data to give management. Additional interventions
included tips on enhancing drug adherence and recognition of possible side effects; printed materials; follow
up calls at 1 week, 1, 2 and 4 months. Nurse contacted physicians to initiate new drugs not did not contact
physicians when changing medication dosage. Increase in drug dose occurred when <80% measurements
met criterion of 130/85mmHg.(1)
Outcomes Usual care
Notes (1) Blood pressure- mean change DBP -6.5 mmHg (E) versus mean change DBP 3.4 mmHg (C)(2) Increase
in taking and intensification of antihypertensive drugs-22% (E) and 30% (C) patients taking antihypertensive
medication, changed to 96% (E) and 78% (C). Significant increase in number taking ?drugs 70% (E) and
46% (C).(3) Improved adherence to mediation-80.5% (E) versus 69.2% (C)Duration of FU 6 months
Allocation concealment B – Unclear
Study Sackett 1975
Methods Factorial RCT
Steel mill employees in Canada
Participants Hypertension 95mmHg on repeated measurement. Not currently treated. n=230.
Interventions (1) Augmented convenience (AC)
Saw on-site physicians during working hours and on full pay versus usual care of seeing their own GP
(2) Mastery learning (ML)
Educational programme designed to give them the facts about hypertension, including compliance advice
and reminders about pill-taking. Information supplied in audio-casette and booklet. Mastery learning re-
emphasised by a ”patient educator“
(3) Both intervention
(4) Usual care
Outcomes (1) Number men placed on BP medication increased in both groups
AC (87/114, 76% vs 57/116, 49%)
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Characteristics of included studies (Continued )
ML (80/115, 70% vs 64/115, 56%)
(2) Compliance- no difference
AC (47/87, 54% vs 29/57, 51%)
ML (40/80, 50% vs 36/64, 56%)
(3) Compliance and at goal BP (<90mmHg)- no difference
AC (20/87, 23% vs 11/57, 19%)
ML (19/80, 24% vs 12/64, 19%)
Duration of FU 6 months
Notes Knowledge improved significantly in the Mastery learning group (85% vs 18%).
Individual compliance rates bore no relationship to knowledge.
Allocation concealment B – Unclear
Study Sanders 2002
Methods Cluster RCT, two of three primary care group practices, Virginia, US. 22 primary care physicians
Participants Hypertension and diabetes, 30 years of older, on medication for both conditions, blood pressure “greater
than normal” on an index visit.
Interventions (1) Chart reminder- consisted on a bright cardstock consisting of information on the following: description
of the problem; recommended target blood pressures, algorithm for suggested care (modified from US JNC
VI guidelines). Participating physicians not reminded in any other way.
(2) Usual care
Outcomes (1) Blood pressure- mean SBP 148mmHg (E) versus 150.87, p=0.14, mean DBP 75.14mmHg (E) versus
77.21mmHg (C), p=0.16
(2) Medication change- 31% (E) versus 36% (C), p=0.51
Duration of FU “as soon as feasible after the chart reminder was placed and the clinic visit conducted.
Notes Cluster RCT analysed at individual level
Allocation concealment B – Unclear
Study Soghikian 1992
Methods Parallel, 430 individuals in four medical centres, California, USA referred by 67 physicians
Participants Hypertensionbut no entryBP level required or defined.DBP<90mmHg in 60% (C) 59% (E), 90-104mmHg
33% (C) 37% (E), 105mmHg 7% (C) 4% (E) patients. 82% (C) 88% (E) patients taking BP lowering
medication.
14% had end organ damage of cardiovascular event during the year of the trial
Interventions (1) Home blood pressure measurement- patients asked to measure BP twice weekly, mail record of BP,
medications and side effects to project office every 4weeks.Data compiled and sent to each patient’s physician.
Non compliant patients were contacted and urged to submit readings.
(2) Usual care
Outcomes (1) Use of medical services- mean number hypertension related office visits 1.2 less in (E) group, telephone
calls 0.8 more in (E) group, procedures per patient the same.
(2) Cost of services- mean cost significantly lower $88.28 (E) vs $125.37 (C)
(3) Blood pressure control lower in (E) group - mean SBP (E) 135.9mmHg versus (C) 142mmHg unadjusted
difference-6.1mmHg NS;DBP (E) 86.2mmHg versus (C) 88mmHg, unadjusted difference -1.8mmHg. NS
(4) Patient and physician satisfaction- high for (E) group
Duration of FU 1 year
Notes Costs lower in (E) group (29%) with a non significant trend in reduction of SBP/DBP.
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Allocation concealment B – Unclear
Study Solomon 2002
Methods Parallel, individuals from ten departments of Veterans Affairs medical centres and one academic medical
centre, US
Participants Treated hypertensive patients (dihydropyridine and/or diuretic therapy) (n=133), 64% caucasian, 28% black,
96% men, mean age 67 years,
Interventions (1) Patient-centred pharmaceutical care model (employing standardised care) implemented by clinical phar-
macy residents, scheduled visits at one-month intervals for a total of five visits
(2) Usual care
Outcomes (1) Blood pressure control- SBP improved (E) 138.5mmHg versus (C) 144.9mmHg (p<0.05), DBP (E)
80.2mmHg versus (C) 83.2mmHg NS
(2) Compliance (pill count, self report)- better compliance scores (0.23 vs 0.61) in (E) group (p<0.05)
(3) Mean number of hospitalisations/other health care provider visits- significantly higher in (C) group
Duration of FU 6 months
Notes Losses to follow up not reported
Allocation concealment B – Unclear
Study Takala 1979
Methods Hypertensive patients identified through systematic screening of 1245 individuals. To be included had to
have two BP readings, six months apart with high blood pressure on not on BP treatment
Participants Hypertensive patients in Finland, n=147, aged 40-49, SBP 160mmHg or DBP 95mmHg; aged 50-64, SBP
170mmHg or DBP 105mmHg. Drug treatment started in 78/93 (84%) in intervention group and 86/100
(86%) in control group
Interventions (1) ”Improved treatment system“ included:Written treatment instructions.Card with details of BP readings,
drugs prescribed, time of next appointment.Appointments at one monthly intervals.Invitation for outpatient
review; appointment if defaulted on any appointment.(2) Usual care
Outcomes (1) ”Dropping out“ of system- failing to keep outpatient follow up appointment. Improved in (E) 3/100
versus (C) 16/102(2) Control of SBP/DBP reported separately in two age groups (aged 50)(3) % patients in
each group who attained BP goal, 31% (E) vs 17% (C)Duration of FU 1 and 2 years.
Notes
Allocation concealment B – Unclear
Study Takala 1983
Methods Hypertensive patients identified through systematic screening of 1245 individuals. To be included had to
have two BP readings, six months apart with high blood pressure on not on BP treatment
Participants Hypertensive patients in Finland, aged 40-49, SBP 160mmHg or DBP 95mmHg; aged 50-64, SBP
170mmHg or DBP 105mmHg. Drug treatment started in 78/93 (84%) in intervention group and 86/100
(86%) in control group
Interventions (1) ”Improved treatment system“ included:Written treatment instructions.Card with details of BP readings,
drugs prescribed, time of next appointment.Appointments at one monthly intervals.Invitation for outpatient
review; appointment if defaulted on any appointment.(2) Usual care
Outcomes (1) ”Dropping out“ of system- failing to keep outpatient follow up appointment. Improved in (E) 3/100
versus (C) 16/102(2) Control of SBP/DBP reported separately in two age groups (aged 50)(3) % patients in
each group who attained BP goal, 31% (E) vs 17% (C)Duration of FU 1 and 2 years.
Notes
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Allocation concealment B – Unclear
Study Tanner 1981
Methods Hypertensive patients attending in a single urban family practice.
Both groups visit family practice every 2 weeks for 4 months- total 8 appointments.
Participants Diagnosis of hypertension from computer search with DBP 90mmHg, age 18-65. 50 identified, 30 agreed
to participate, 11 males. 14 black
Interventions (1) Intervention group given ”Guide to essential hypertension“ content included: hypertension; medication;
diet; stress; exercise; smoking; lifestyle; bp monitoring techniques. Encouraged to ask questions and discuss
problems when they at practice visits.
(2) Usual care
Outcomes (1) Knowledge- baseline and follow up-within group comparison knowledge
E-13.53 to 14.40 increase
C- 13.26 to 13.26 no change.
Between group score significantly better in E versus C group.
(2) Control of DBP- no difference
Duration of FU 4 months
Notes
Allocation concealment B – Unclear
Study Tobe 2006
Methods
Participants
Interventions
Outcomes
Notes
Allocation concealment D – Not used
Study Vetter 2000
Methods Parallel, individuals 244 practitioners in Switzerland, 4 patients per practitioner recruited
Participants Hypertension, SBP 160-200mmHg or DBP 95-115mmHg in untreated patients or uncontrolled patients
or who wished to change BP lowering drug because of low tolerance
Interventions (1) Home measurement of blood pressure by patients
(2) Usual care
Outcomes (1) Blood pressure control- SBP improved (E) 145.1mmHg versus (C) 147.6mmHg(p=0.02),DBP improved
(E) 88.7mmHg versus (C) 90.1mmHg (p=0.038). (2) % with controlled hypertension (DBP 90mmHg)
66.2% (E) vs 59.8mmHg (ns)
Duration of FU 8 weeks
Notes All patients treated with same BP lowering drug, Losartan 50mg once daily. No compliance data so not
possible to say improved BP control due to improved compliance. Home BP measurement produced small
BP change at 8 weeks
Allocation concealment B – Unclear
Study Watkins 1987
Methods 6 General practices UK
n=414, 41% male
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Characteristics of included studies (Continued )
Participants Hypertension determined from medical records age range 35-64
Interventions (1) Information booklet on hypertension sent out to patients
(2) Usual care
Outcomes (1) (1) Systolic blood pressure- no difference 149.2mmHg (C) versus 149.8mmHg (E)
(2) Diastolic blood pressure- no difference 94.9mmHg (C) versus 95.3mmHg (E)
(2) Knowledge- slight increase in knowledge score in intervention group
Duration of FU 1 year
Notes Drop outs not reported in each arm
Allocation concealment B – Unclear
Study Webb 1980
Methods Parallel, individuals who were patients of 14 family practice residents US
Participants Patients had to have at least: one year history of hypertension; uncontrolled DBP 90mmHg; taking BP
lowering drugs
Interventions (1) Education- three group education sessions by nurse-health educator (causes, nature, implications and
treatment of hypertension)
(2) Counselling- three ”individualized“ counselling sessions
(3) Usual care- three appointments with family physician
Outcomes (1) DBP- no difference between either group and usual care- education (E1) 88.9mmHg versus (C)
88.1mmHg, counselling (E2) 87.4mmHg versus 88.1mmHg
(2) Compliance- no difference between either group and usual care
(3) Return for follow up appointment- no difference education (E1)10.1 versus (C) 10.2, counselling (E2)
11.2 versus 10.2
Duration of FU 6 months
Notes Negative RCT, data pooled from education arm of trial
Allocation concealment B – Unclear
Study Zarnke 1997
Methods Parallel individuals from eleven family physicians and one tertiary hypertension research unit, Canada
Participants Age 52 (E) 56 (C), 13 (42%) male, average BP readings <160/95, taking BP lowering drugs or receiving
non-pharmacological advice
Interventions (1) Patient-directed group - instructed in homeBPmeasurement,measured ownBP twice daily and instructed
by means of algorithm to change own BP medication, if still exceed goal to contact family doctor
(2) Office-based group- adjustments to BP medication made by family doctor
Outcomes (1) Change in daytime mean arterial BP adjusted for baseline measurement- decreased significantly in (E)
group -0.95 versus +1.9 (C)
(2) Compliance (doses missed per week- (E) 0.05 versus (C) 0.2 NS
(3) Quality of life scores- no difference
(4) Indices of health care resource use- total number of physician visits significantly greater in (E) group, no
difference in total number of BP drugs used
Duration of FU 8 weeks
Notes Small RCT (n=31), short period of follow up
Allocation concealment B – Unclear
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Study Zismer 1982
Methods Hypertensive patients in a single urban family practice. 176 eligible, 50 randomly selected, 39 agreed to take
part.
3 groups- two separate intervention groups treated as the same in the analysis.
Participants Diagnosis of hypertension or receiving BP lowering drugs or elevated BP for 2 consecutive visits 140 or
90mmHg within previous 12 months
37 black, 21 male, average age 45 (E) 56 (C), age range 21 to 76.
Interventions (1) Experimental group A- Educational ”self-care“ intervention: pill taking; appointment keeping; dietary
sodium reduction
(2) Experimental group B-received additional support from family member.
(3) Usual care
Outcomes (1) Systolic blood pressure- improved 150.9mmHg (C) versus 130.5mmHg (E), p<0.01.
(2) Diastolic blood pressure- improved 92mmHg (C) versus 85mmHg (E), p<0.001.
(3) Frequency of visits- no difference between groups in mean number of visits
Duration of FU 6 months
Notes BP readings at baseline and FU were mean of last 3 readings
Control group was not similar to experimental group: 10 years older and diagnosed for longer
Allocation concealment B – Unclear
Characteristics of excluded studies
Study Reason for exclusion
Andrejak 2000 Randomised trial of once daily versus twice daily ace inhibitor. Outcome compliance as judged by mem’s
monitored. Once daily medication better than twice daily dosage. Included in adherence systematic review.
Excluded: adherence RCT
Bachman 2002 Accuracy and quality of self-reported home blood pressure values assessed. 48 patients randomised to receive
information about storage capabilities of a home measuring device or not. Accuracy and interpretation of
home blood measurement increased in the informed group. Reason for exclusion: intervention not aimed
directly at improving blood pressure control; no blood pressure data reported.
Barron-Rivera 1998 Randomised trial of education programmed to patients. Outcome was well-being and quality of life. Excluded:
no report on blood pressure control in the process of care.
Ben Said Randomised trial of assessment education interventions - same trial as reported by Consoli. Excluded: no
outcome on blood pressure or process of care reported.
Binstock 1988 Excluded because no “usual care” group.
Birtwhistle 2004 Equivalence RCT of three month versus six month follow up.
Reason for exclusion:
(1) Neither intervention met inclusion criteria of the review. No additional intervention directed at either
patient, health professional or organisation of care.
Finding that BP control was equivalent between three and six month follow up arms of the study. Both groups
saw health professional much more often than planned over the three years- mean (sd) visits per patient in
three month group 18.8 (8.06) versus 16.2 (8.45) in six month group.
Blenkinsopp 2000 Parallel, cluster randomised, 20 community pharmacy sites, UK. 180 treated hypertensives, 62% age 60 or
over. (1) Pharmacist delivered, Structured, brief questioning protocol on medication problems; including
advice, information and referral to general practitioner versus usual care, delivered three times at two-month
intervals
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(2) Usual care. (1) % with controlled hypertension- of those patients with initially uncontrolled hypertension
( 160/90mmHg) (E) 35.7% versus (C) 17.1% were controlled at follow up (p<0.05), no difference in BP
control in those who were controlled at start of study
(2) Compliance (self report)- 62% (E) versus 50% (C) (p<0.05)
(3) Patient satisfaction- high level with service and no significant differences between groups. Duration of FU
6 months. Substantial losses to follow up. Subgroup analysis of % controlled blood pressure, therefore not
included in analysis. Reason for exclusion: no blood pressure data.
Bond 1984 Non-randomised trial of clinical pharmacologist nurse clinician improving drug documentation, for blood
pressure control and rheumatology/renal screening. Excluded: no BP outcome data
Broege 2001 40 hypertensive men and women randomly assigned to “home” self measurement with subsequent manage-
ment and medication change compared to “clinic” group where medication adjusted based upon readings
taken by project nurse.
Reasons for exclusion:
1. Includes treated and untreated hypertensive patients. Drug treatments adjusted downward or treatment
initiated depending on BP reading and drug treatment status. Not possible to detect effect of self monitoring
on treated blood pressure alone.
2. No usual care- both groups experiencedmonitoring- self monitoring at home or nurse monitoring in clinic.
Cappuccio 2004 Systematic review of home monitoring. 18 RCTs included- several RCTs excluded from this review that
Cappucion included. These are (with reasons why excluded from this review in brackets):
Binstock- no usual care group included.
Stahl- non randomised trial, patients allocated “sequentially”.
Midanik-
Caro 1998 Non-randomised trial. Observational study of compliance and persistance with therapy, excluded for these
reasons.
Celis 1998 A randomised controlled trial protocol comparing self measurement of blood pressure against conventional
blood pressure measurement. Protocol of trial. Excluded: no results reported.
Charlesworth 1984 Quasi randomised trial. Patients assigned random numbers and then rank ordered. The first 32 were given
intervention, the next 22 were in the control group. Intervention was of stress management outcome SBP and
DBP was significantly reduced in the stress management group. Excluded: intervention and wasn’t properly
randomised.
Consoli Randomised trial of computer assisted programme intervention was educational. Outcome knowledge in-
creased at two months in intervention group compared to control. Excluded as no outcome on blood pressure
or process of care reported.
Consoli SM, Ben2 Randomised trial of computer assisted programme intervention was educational. Outcome knowledge in-
creased at two months in intervention group compared to control. Excluded as no outcome on blood pressure
or process of care reported
Consoli SM, Ben3 Randomised trial of computer assisted programme intervention was educational. Outcome knowledge in-
creased at two months in intervention group compared to control. Excluded as no outcome on blood pressure
or process of care reported
Cranney 1999 Non-randomised trial 9 pairs of practices matched by means of overall blood pressure control and then
randomised to eductional intervention directed to health professionals in the practice. The outcome was a
stated threshold for blood pressure control. Excluded because of non-randomised trial design.
Denver 2003 120 Type 2 diabetic patients with uncontrolled hypertension (BP >140/90) randomised to usual GP care
or nurse-led outpatient care. Nurse led care associated with improved systolic blood pressure. Reasons for
exclusion: (1) patients allocated by means of alternation rather than randomisation (2) setting.
Djerassi 1990 Non-randomised trial, before/after design. Intervention was based in factories program of follow-up treatment
by planned doctor and nurse versus usual care by family doctor in other factories. Outcomes number of
percentage of people treated with an intervention group was greater.
Dusing 1998 Observational study of 1603 patients in 320 private practices in Germany. Investigated change in antihyper-
ensive theapy within six months of start of study. Inadequate BP control most important reason for change
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in 48.4% of patients in the cohort, others include: adverse effects 30.1%, patient dissatisfaction 20%, non-
compliance 16.8%, cost 4.9%.
Erickson 1997 A non-randomised trial of pharmacist care which involved reviewing medical records, taking drug history,
assessing patients specific drug issues, concerns about taking drugs, lifestyle, compliance and knowledge all
direct to the patient. Outcomes SBP and DBP were reduced in the group who received a pharmacist’s care at
5 months. Quality of life measures were the same. Trial excluded because it was not randomised.
Flack 1995 Observational study reporting adherence rates with different classes of anti-hypertensive agents.
Flack 2000 Randomised trial of slow versus fast titration of blood pressure lowering drugs.
Foote 1983 Quasi randomised controlled trial. Four interventions, screening and referral to physician, referral to physician
and semi-annual follow-up, referral to physician andmore frequent follow-up, and on-site treatment.Outcome
was the number of people under treatment, control and proved in the last three groups.
Girvin 1999 A randomised trial cross-over design of single versus twice a day Enalapril. The outcomes were of compliance
which increased with the single dose medication and blood pressure control which is better in the twice a day
medication group. Reason for exclusion, adherence randomised trial, included in the adherence systematic
review.
Godley 2003 Evaluation of a quality improvement programmefor hypertension management. Intervention consisted of
educating healthcare providers and recommending appropriate pharmacotherapy for compelling indications.
30,721 hypertensive patients identified from pharmacy claims, 417 patients randomly selected for note review.
Overall level of blood pressure control stated to have improved from 37.2% to 49.2% at follow up. Reason
for exclusion: not a randomised study; no comparison group.
Gonzalez-Fernandez Parallel, individuals, hospitalised for “non-hypertensive related diseases) in a single hospital, Puerto Rico. 60
treated hypertensives, 55%women, mean age 59 years. (1) In-hospital education- 4 educational interventions:
”knowing high BP“ by a physician; ”diet and high BP“ by a dietician; ”exercise and high BP“ by a health
educator; ”medications and compliance in high BP“ by physician and pharmacy student. (2) Usual care. (1)
Blood pressure control- SBP and DBP improved in (E) 137mmHg versus (C) 154mmHg (p=0.005), diastolic
(E) 89mmHg versus 98mmHg (p=0.006)
(2) Compliance (direct questioning and pill count)- adherence improved by 66% in the intervention group
compared to 16% in usual care group (p=0.04). Reason for exclusion: hospital-based RCT.
Duration of FU 8 weeks
Grimm A randomised trial of four different class of anti-hypertensive agents and quality of life. Excluded: no data on
BP control, no interventions other than different classes of anti-hypertensive drugs.
Hatcher 1986 Factorial randomised trial of health education intervention. Three levels of intervention medication schedules,
diet, appointment keeping, familymember, reinforcements and small groupmeeting. Excluded as intervention
was based on ? ? education and no outcomes on blood pressure control in the process of care.
Herbert 2004 2x2 factorial RCT of 28 peer learning groups involving 200 family physicians in British Columbia, Canada.
Interventions: personalised prescribing feedback relating to hypertension; case-based educational module.
Evidence-based prescribing improved in both groups (increase in thiazide prescribing as first line agents).
Reason for exclusion: no blood pressure outcomes reported.
Hyman Questionnaire study self reported physician practice excluded for that reason.
Inui 1976 Before/after study interventionwith tutor physician educating patients regarding their hypertension. Excluded:
not a randomised trial.
Iso 1996 Randomised trial of health education advice (non-pharmacological) follow-up was at 6 months and one and
half years. Excluded: intervention was based around health education/counselling advice.
Iso H, Randomised trial of health education classes to patients. Excluded as intervention was non-pharmacological
advice.
Jennett 1986 RCT of continuing medical education in the context of treatment of hypertension. Intervention focussed on
three learning objectives: 1) physicians reschedule diagnosed hypertensive patients (aged 50 years or older)
not as yet in control, to be seen at least every month until controlled; 2) physicians take blood pressure of
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hypertensive patients in the supine position and also within one minute after standing on every visit and the
patient’s position is recorded with their blood pressure record; 3) physicians ask patients who have not yet got
controlled blood pressure about their compliance in taking prescribed medication and record the answer. Two
educational formats used: 1) six to eight page educational newsletters; 2) small group discussion. Behaviour
change improvement scores with the intervention group compared to control. Behaviour was sustained 12
months post education. Reason for exclusion: no blood pressure data reported.
Kawachi 1991 Non-randomised trial. Cost effectiveness analysis.
Krishan 1979 Non-randomised trial of nurse practitioner and integrated physician supervised management in community
hypertension clinics versus usual care. No difference in outcome of blood pressure control.
Levine 2003 RCT of community health workers providing less intensive care (education, counselling and information
about gaining access to free ongoing care in the community) versus more intensive care (all components
of less intensive intervention plus additional home visits, further educational messages and social support
mobilization through family members) . At 40 months follow up, both groups experienced improvement
in blood pressure control (signiticant within group difference from baseline blood pressure readings). Less
intensive group had greater blood pressure control compared to more intensive group but difference was not
significant. Reason for exclusion: no usual care group.
Lewis 1967 Randomised trial of nurse clinics versus usual care in outpatient clinic. The population included patients
with Hypertension and Atherosclerotic Disease, Obesity, Arthritis and Psychophysiological Disorders. The
outcomes are preferences for care, costs and process of care in terms of examinations and investigations.
Excluded: no data on process or outcome of blood pressure care.
Linjer 1997 Non-randomised trial. Discussion paper regarding percentage of patients eligible in randomised trials generally
at low risk in trial participants.
Littenberg 1990 Non-randomised trial. Cost effectiveness study of increased blood pressure.
Marquez 2000 Randomised trial intervention being health education through group sessions with postal back-up. Outcomes
were compliance with blood pressure medication. Excluded as no outcome in terms of blood pressure control
reported
Mashru 1997 Before after study of interpractice audit following educational programme concerning diagnosis and man-
agment of hypertension. Six general practices in NW London, UK, 750 hypertensive patients. At two years
follow up, two thirds of patients remained ”uncontrolled“ (BP<160/90).
McDowell 1989 Non hypertensive patients registered with a large family practice (Canada). Interventions: computer reminder
to GP, letter to patient, nurse telephone call to patient. Outcome was whether blood pressure was checked or
not. Effect of reminders was ”modest“
McInnes 1995 Non-randomised trial two patients were matched and then randomised to it. Shared care or clinical care.
The intervention was computerised shared care versus hospital clinical care in outpatients departments. The
outcome showed there were less drop-outs for shared care and they were better adequately used in terms of
patient management in shared care compared to usual care. Shared care was more cost effective. Blood pressure
control was similar in both groups.
McKenney 1973 A pharmacist intervention directly at patients improved knowledge compliance with medication and blood
pressure control, however not randomised properly. Patients assigned consecutive numbers then randomised
according whether they had odd or even numbers
Murray 1988 Not hypertensive patients. Population: persons ”at risk“ of developing hypertension. Intervention: direct mail
to prompt attendance at clinic, either single, multiple or no mail. Outcome: number of patients who had a
blood pressure checked or discussed with their physician
New 2003 Specialist nurse-led clinic in a single outpatient clinic in Salford, UK. Population: diabetic patients receiving
hospital-based care. Comparison group: usual hospital care. Outcome: improvement in blood pressure and
hyperlipidemia targets acheived with intervention. Reason for exclusion: hosptial-based, (2) diabetic patients.
Pheley 1995 Observational study of nurse based hypertension clinic with no comparison group.
Putnam 1989 40 family physicians from theDalhousie University Division of Continuing Medical Education separated into
3 groups according to extent of involvement in establishing essential criteria for hypertension managment.
48Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
No difference in control of blood pressure in these family physician’s patients at 18 months follow up. Reason
for exclusion: non randomised trial
Ramsay 1996 Non-randomised trial. Discussion paper.
Staessen 2004 Randomised trial of treatment based on (1) BP measured at home (3 consecutive measurements twice daily)
versus (2) BP measured at physician’s office (average of 3 consecutive readings taken by physician during
practice hours).
Reason for exclusion:
(1) Assessed self monitoring in the context ”as guides to initiate and titrate antihypertensive drug treatment“.
(2) Treated and untreated patients included.
At follow-up (median 350 days), more home BP than office BP patients had stopped antihypertensive drugs
with no difference between groups of patients who had progressed to multiple drug treatment. Final office,
home and 24-hour ambulatory BP measurements were higher in the home BP group than in the office BP
group.
Stahl 1984 Non-randomised trial. Self and family read blood pressure monitoring groups plus nurse education. Excluded
because of non-randomised study.
Statson 1977 Non-randomised trial. Examining the cost effectiveness of treatment of hypertension
Stephenson 1999 Non-randomised trial.
Trocha 1999 91 hypertensive type 1 diabetic patients with overt diabetic nephropathy followed for 10 years. Intensfied
versus routine antihypertensive treatment. Blood pressure control and survival improved in the intensified
group. Reason for exclusion: non randomised study
Tu 1999 Parallel, individuals 222 attending a ”health unit clinic“, carried out in a veteran home in Taiwan, China.
Hypertension, SBP 140 or DBP 90 in untreated patients or treated hypertension patients BP level not stated.
Average age 74.6 years. (1) Medical education group (MEG)- monthly meeting concerning cognition, attitude
self-care behaviours for hypertension
(2) Health education- same content but delivered every other month group (EOMG). Differences between
groups not clearly reported. Stated that no difference in attitudes and behaviour between groups. Blood
pressure no difference in SBP but higher DBP in EOMG. Between group differences not clearly stated. Table
3, within group differences all improved for ”cognition, behaviours and attitudes“ scores and ”blood pressure
marking“ changes. Duration of FU 6 months. Reason for exclusion: no BP data for both arms of study
reported.
UK PDS 1998 Randomised trial of tight less tight blood pressure control. Excluded because its not reporting on process and
organisational issues in hypertension care.
Waeber 1999 Randomised trial of compliance in terms of aspirin versus placebo from the HOT randomised controlled trial
Weiner 1980 Cluster- six ”industrial settings“ randomised. Ohio county clinics US, SBP>140 or DBP >90 age 19-39,
SBP >150 or DBP >90 age 40-64. (1) Nurse management. Involved reinforcement to take medication,
information about side effects of medications, diet instruction, BP checks, weight checks, education and
counselling regarding ”an understanding and acceptance of hypertension“, (2) Usual care. Positive RCT
reported. Experimental patients had better:
(1) Decreases in maximum SBP (p=0.02)
(2) Average SBP (p=0.02)
(3) % overweight (p=0.01)
(4) Improved knowledge (p=0.002). Duration FU 3 months. No difference found for maximum and average
DBP between (E) and (C). Only very brief account of RCT with no details of baseline or follow up blood
pressure. Reason for exclusion: no blood pressure data.
Weir 2002 Questionnaire survey a combination of lifestyle medication taking in half outcomes
Wollard 1995 Randomised trial at two levels of intensity, lifestyle advice/counselling from practice nurses. Outcome was
lifestyle and non-pharmacological change in patients. Excluded because intervention was based on non-
pharmacological advice and outcomes included lifestyle changes. Of note intervention was more effective than
usual care.
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Characteristics of excluded studies (Continued )
Wyka-Fitzgerald 1984 Randomised trial of nurse education programme directed at patients intervention was non-pharmacological
advice so excluded for this reason.
Zernike 1998 Randomised trial of structured patient-centred education programme versus normal information. Outcome
patient knowledge which was increased and structured intervention. Excluded as no outcomes reported on
blood pressure control or process of care.
van den Hoogen 1990 Non randomised study. ”Experimental“ study but no mention of randomisation. 15 general practices in the
Netherlands, newly detected patients with hypertension two years prior to start of study aged 36-55 years.
Intervention: computer-assisted monitoring system, provides monthly feedback on treatment results, regular
meetings at practices where surveys discussed. Outome: improved surveillance and control of blood pressure
in computer group
Characteristics of ongoing studies
Study Coppola
Trial name or title Improving the primary prevention of stroke in older patients in general practice: a randomized controlled trial
Participants Elderly patients (aged between 60 to 75 years) registered in 20 general practices in London UK
Interventions Intervention directed at health professionals in general practices. One hour seminar
Outcomes Blood pressure control
Starting date Not known
Contact information pwhincup@sghms.ac.uk
Notes
Study Krieger
Trial name or title SHIP Clinic-Based Program
Participants 1. Patients currently at a participating clinic with a diagnosis of hypertension.
2. Low income.
3. Caucasian or African American.
4. Aged 18 or older
Interventions 1. Patient care co-ordinator at each clinic.
2. Computerised tracking system.
3. Linkage with outreach workers.
4. Linkage with community-based resources
Outcomes 1. Mean systolic and diastolic blood pressure.
2. Non-pharmacological behaviour change
3. Control of blood pressure
Starting date Not known
Contact information James Krieger
James.krieger@METROC.GOV
Notes RCT complete, anticipated publication in 2003
Study McManus
Trial name or title A randomised controlled trial of patient held targets and self monitoring in the control of hypertension: Targets
And Self Monitoring IN Hypertension (TASMINH)
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Characteristics of ongoing studies (Continued )
Participants 441 patients aged 35-75 with known hypertension (coded by own general practitioner), on antihypertensive
drug treatment with a blood pressure greater than 140/85 at randomisation drawn from eight practices in
Birmingham UK, two practices each drawn from a quartile of Townsend (deprivation) score
Interventions All patients receive information on non pharmacological methods (BritishHypertension Society self help leaflet).
Intervenion group taught to check their own blood pressure using OMRON blood pressure monitor at their
own surgery/practice. Patients asked to check monthly. Patients given British Hypertension Society targets
(140/85 or 148/80 for diabetic patients). Patients requested to attend their family doctor (general practitioner)
to discuss treatment with antihypertensive drugs if their blood pressure reading exceeds target reading two
months continuously. Control group receive usual care from their family doctors (general practitioners)
Outcomes 1. Blood pressure reading at 12 months follow up
Starting date September 2001, last patient randomised March 2002, final follow up March 2003
Contact information Dr Richard McManus r.j.mcmanus@bham.ac.uk
0121 414 2658
Notes RCT nearly complete, anticipate publication late 2003/early 2004
Study Sullivan
Trial name or title HYPER Trial
Participants Elderly (aged 65-79) hypertensive patients majority of patients were taking antihypertensive medication at
baseline
Interventions Aim to evaluate the provision of diferent levels of feedback developed from computerised GP data. 52 Scottish
general practices randomised to three groups:
1. Usual care.
2. Feedback of audit data (information about patients who need either screening, assessment or treatment).
3. Strategic feedback prioritising patients by absolute risk of death from stroke
Outcomes 1. Blood pressure measurement
2. Mean systolic and diastolic blood pressure
3. Blood pressure control
Starting date August 1999
Contact information Liz Mitchell
e.d.mitchell@dundee.ac.uk
Notes RCT complete, data being analysed and report should be in the public domain in 2003
Study Zarnke
Trial name or title Not known
Participants Patients with uncontrolled hypertension
Interventions Patient-directed self measurement
Outcomes 1. Blood pressure measurement2. Mean systolic and diastolic blood pressure3. Blood pressure control
Starting date Not known
Contact information kelly.zarnke@lhsc.on.ca
Notes RCT complete, data being analysed
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(Continued )
A D D I T I O N A L T A B L E S
Table 01. Quality of included randomized trials
Study ID Randomization Allocation concealed Blinding Losses to follow up
Carnahan Method not stated Not stated No 1/50 (E- 2%)
2/50 (C- 4%)
1/50 (E- 2%)
2/50 (C- 4%)
1/50 (E- 2%)
2/50 (C- 4%)
Hawkins Method not stated Not stated No 225/574 (E- 39.2%)
294/574 (C-51.2%)
Evans Method not stated Not stated Yes- BP check Staff
”blind“ to allocation
group
5/107 (E- 5%)
10/91 (C- 11%)
Hypertension Detection
and Follow up (HDFP)
Randomisation done
centrally, stratified by
centre (n=14) and entry
DBP strata (n=3)
Yes, coordinating centre
prepared sealed opaque
envelopes. An envelope
was drawn sequentially
and attached to
participant’s data form
at the time of DBP
screening. Envelope
opened after baseline
No- neither participant
or clinic blind to
randomisation. BP
outcome not blinded
967/5485 (E- 17.6%)
938/5422 (C-
17.2%) status of
antihypertensive drug
treatment not known at
1 year
(includes lost to
FU/dead/missing data)
Jewell Method not stated Not stated No 15/17 (E- 12
19/19 (C- 0%)
Cummings ”Randomisation list“ Not stated Yes 446\486 (E- 8%)
420\487 (C- 14%)
Tanner ”Randomly assigned
through a table of
random numbers“
Not stated No 15/15 (E- 0%)
15/15 (C- 0%)
Zismer Not stated Not stated No 26/26 (E- 0%)
13/13 (C- 0%)
Watkins Not stated but stratified
by age, sex, practice and
last recorded BP
Not stated Yes 414/565 (Overall- 27%)
Rogers Randomisation stratified
by # prescription
medications
Yes- to physicians and
clinical research staff but
once completed ”open“
No 56/60 (E-7%)
55/61 (C- 10%)
Muhlhauser Randomisation process
for 10 participating
practices. 20 patients
per practice selected
by means of random
number chart
Not stated No 86/100 (E- 14%)
74/100 (C- 26%)
Montgomery Randomisation by
means of random
Yes No 202/229 (E 1 12%)
199/228 (E 2- 13%)
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Table 01. Quality of included randomized trials (Continued )
Study ID Randomization Allocation concealed Blinding Losses to follow up
number table by
a researcher not
involved in study.
Practices stratified by
computer system used
(2 alternative computer
systems)
130/157 (C- 17%)
Takala Method not stated Not stated No 25/100 (E- 25%)
32/102 (C- 31%)
Sackett Method not stated Not stated Yes Factorial RCT
(1) Convenience
Augmented 6/114 (E-
5%)
Normal 4/116 (C- 3%)
(2) Mastery learning
Yes 8/115 (E-7)
No 2/115 (C- 2%)
Haynes Minimisation, method
not stated, patients
stratified according to
important prognostic
factors in previous RCT
by Sackett20
Not stated Yes 0/20 (E- 0%)
1/19 (C- 5%)
Logan Method not stated Not stated Yes 26/232 (E- 11%)
21/204 (C- 9%)
Johnson Method not stated Not stated Yes Factorial RCT
(1) Self recording of
blood pressure
(E- 34/36- 6%)
(2) Home visits
(C-34/36- 6%)
Brook By means of ”random
sampling techniques
that made the
distribution of family
characteristics in each as
similar as possible“
Not stated No Free care versus 3 forms
of cost-sharing plans.
Blood pressure outcome:
Free care (E- 134/294,
46%)
Cost share (C-
Earp Method not stated Not stated No 3 arm RCT
Follow up at year 1 and
2
Group 1-
1 year- 74/99, 25%
2 year- 55/99, 44%
Group 2-
1 year- 41/56, 27%
2 year- 39%
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Table 01. Quality of included randomized trials (Continued )
Study ID Randomization Allocation concealed Blinding Losses to follow up
Group 3(control)-
1 year- 47/63, 25%
2 year- 38/63, 40%
Martinez-Amenos Method not stated Not stated No No details on losses to
FU provided
McAllister Practice cluster stratified
by:
1) partners
2) Ethnicity
randomisation by
”shuffled deck of cards“
Not stated No 5/30 (E- 17%)
5/30 (C- 17%)
Bogden Randomisation by last
digit of social security
number:
Odd # (E)
Even # (C)
Not stated Yes 1/50 (E- 2%)
4/50 (C- 8%)
Fielding Randomisation by
means of random
numbers table
Not stated No 6/80 (E- 7%)
8/79 (C- 10%)
Morisky and Levine Randomisation through
”simple random
sampling procedures“
Not stated No Overall 64/400 (16%)
Control of BP
(C)
40/50 (20%) 2 yrs
30/50 (40%) 5 yrs
(E) all 3 intervention
44/50 (12%) 2 yrs
42/50 (16%) 5 yrs
Zarnke Randomisation by
means of computer
generated list in blocks
of six. Asymmetric
allocation scheme (2:1
E:C)
Not stated No 0/20 (E- 0%)
1/11 (C- 9%)
Roca-Cusachs Research nurse
”allocated every patient
to one of the two groups
using a random scale
balanced for age and
BP“
No Yes 54/138 (E- 39%)
38/149 (C- 26%)
Soghikian Method not stated Not stated No 15/215 (E- 7%)
25/215 (C- 12%)
Billault Method not stated Not stated No 82/101 (E- 19%)
85/99 (C- 14%)
Gullion Method not stated, Not stated Yes (1) Medical- 27
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Table 01. Quality of included randomized trials (Continued )
Study ID Randomization Allocation concealed Blinding Losses to follow up
physicians stratified
according to four
criteria:
(1) % patients whose
DBP controlled.
(2) % patients
responding to the
survery
(3) Physician’s ethnic
group
(4) Specialty
(2) Behavioural- 28
(3) Both- 30
(4) Neither- 27
Friedman Randomized ”using a
paired randomisation
protocol“
Not stated Yes 23/133 (E- 17%)
11/134 (C- 8%)
Hetlevik Method not stated Not stated No 816/984 (E- 17.1%)
/1255 (C- 18.5%)
Krieger Randomisation based
on computer-generated
random number table
Sealed opaque
envelopes, sequentially
numbered. Not
clear who allocated
individuals to groups
No 146/209 (E- 30.1%)
165/212 (C- 22.2%)
Dickinson Method not stated Not stated No 51/51(E feedback- 0%)
78/78 (E education-
0%)
88/88 (E both- 0%)
33/33 (C neither- 0%)
Barnett Method not stated but
stratified by age and
intial DBP ( 100mmHg
or <100mmHg)
Not stated No 44/63 (E- 30%)
27/52 (C- 48%)
Bulpitt Method not stated Not stated No 25/136 (E- 18%)
36/142 (C- 25%)
Coe Method not stated Not stated Yes 56/56 (E- 0%)
60/60 (C- 0%)
Robson Random number tables Not stated No ?/1620 (E- ?%)
?/1586 (C- ?%)
Bloom Method not stated Not stated Yes 12/27 (E- 44%)
19/27 (C- 74%)
Fletcher Patients were ”divided
by meams of a table of
random numbers“
Not stated Uncertain 144/155 (93%)
followed up at five
months. Group losses to
FU not reported
Bailey Method not stated Not stated Yes 29/30 (E- 3%)
31/32 (C- 3%)
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Webb Method not stated Not stated Yes 37/37 (E1-0%)
31/31 (E2-0%)
55/55 (C-0%)
Hamilton Method not stated Not stated No 0/17 (E- 0%)
4/17 (C- 24%)
Park Method not stated Not stated No 5/32 (E- 16%)
6/32 (C- 19%)
Mehos Yes ”randomized using a
deck of cards“
Not stated No 2/20 (E- 10%)
3/21 (C- 14%)
Pierce Yes ”minimisation“ Not stated Yes 59/59 (E health
education)-0%)
54/57 (E monitor-
8.5%)
Solomon Yes, random number
tables
Not stated No 63/63 (E- 0%)
70/70 (C- 0%)
63/63 (E- 0%)
70/70 (C- 0%)
Burelle Not stated Not stated No 8/8 (E- 0%)
8/8 (C- 0%)
Ahluwalia Yes, computer generated
random number table
Not stated No 8/8 (E- 0%)
8/8 (C- 0%)
Vetter Not stated Not stated No 296/296 (E- 0%)
326/326 (C- 0%)
Garcia-Pena Randomisation by
computer
Yes Yes 345/345 (E- 0%)
338/338 (C- 0%)
Artinian Method not stated Not stated No 6/6 (E), 9/9 (C)
Midanik Method not stated Not stated No 74/102 (E- 28%)72/102
(C- 30%)
New Method not stated Not stated No 99/506 (19.6%) in
intervention group
compared to 132/508
(26.0%) in control
group
Rudd Computer-generated
assignment
Not stated Blind outcome
assessment
74/74 (E-0%)74/74
(0%)
Ornstein ”Balanced adaptive
randomisation scheme“,
3 practice characteristics
were: practice specialty,
practice size and
geographical location
Not stated No- open RCT 4446/4446 (E- 0%)
3326/3326 (C- 0%)
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A N A L Y S E S
Comparison 01. Active intervention versus control
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Self monitoring (systolic blood
pressure)
10 1860 Weighted Mean Difference (Fixed) 95% CI -2.50 [-3.87, -1.13]
02 Self monitoring (diastolic
blood pressure)
12 1966 Weighted Mean Difference (Fixed) 95% CI -2.03 [-2.69, -1.38]
03 Self monitoring (BP control) 4 948 Odds Ratio (Fixed) 95% CI 0.88 [0.67, 1.15]
11 Patient education (systolic
blood pressure)
7 1136 Weighted Mean Difference (Fixed) 95% CI -2.54 [-4.55, -0.53]
12 Patient education (diastolic
blood pressure)
9 1258 Weighted Mean Difference (Fixed) 95% CI -0.81 [-1.83, 0.21]
13 Patient education (BP control) 5 530 Odds Ratio (Fixed) 95% CI 0.66 [0.44, 1.01]
21 Physician education (systolic
blood pressure)
6 2839 Weighted Mean Difference (Fixed) 95% CI -2.03 [-3.45, -0.62]
22 Physician education (diastolic
blood pressure)
6 2839 Weighted Mean Difference (Fixed) 95% CI -0.43 [-1.12, 0.27]
23 Physician education (BP
control)
6 13985 Odds Ratio (Fixed) 95% CI 0.85 [0.80, 0.91]
31 Health professional led care
(systolic blood pressure)
6 1685 Weighted Mean Difference (Fixed) 95% CI -2.37 [-3.79, -0.95]
32 Health professional led care
(diastolic blood pressure)
7 2095 Weighted Mean Difference (Fixed) 95% CI -1.53 [-2.09, -0.97]
33 Health professional led care
(BP control)
5 1271 Odds Ratio (Fixed) 95% CI 0.24 [0.18, 0.32]
41 Organisation/protocol driven
care (systolic blood pressure)
7 7072 Weighted Mean Difference (Fixed) 95% CI -8.55 [-9.40, -7.70]
42 Organisation/protocol driven
care (diastolic blood pressure)
7 7072 Weighted Mean Difference (Fixed) 95% CI -4.58 [-4.98, -4.19]
43 Organisation/protocol driven
care
5 11406 Odds Ratio (Fixed) 95% CI 0.43 [0.40, 0.46]
51 Appointment reminder
(appointment interventions)
(outcome: lost to follow up at
clinic)
6 1704 Odds Ratio (Fixed) 95% CI 0.41 [0.32, 0.51]
I N D E X T E R M S
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 Active intervention versus control, Outcome 01 Self monitoring (systolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 01 Self monitoring (systolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bailey 1998 31 -8.00 (19.40) 29 -13.00 (19.00) 2.0 5.00 [ -4.72, 14.72 ]
Carnahan 1975 49 -18.00 (18.50) 48 -10.50 (14.90) 4.2 -7.50 [ -14.18, -0.82 ]
Friedman 1996 110 -11.00 (13.40) 123 -10.60 (13.70) 15.4 -0.40 [ -3.88, 3.08 ]
Mehos 2000 18 -17.10 (15.80) 18 -7.00 (13.90) 2.0 -10.10 [ -19.82, -0.38 ]
Rogers 2001 56 -4.90 (13.50) 55 -0.10 (13.40) 7.5 -4.80 [ -9.80, 0.20 ]
Soghikian 1992 200 -1.50 (13.90) 190 1.80 (17.00) 19.6 -3.30 [ -6.39, -0.21 ]
Vetter 2000 296 -21.00 (14.50) 326 -20.50 (14.30) 36.4 -0.50 [ -2.77, 1.77 ]
Artinian 2001 6 -25.00 (13.80) 9 1.00 (14.10) 0.9 -26.00 [ -40.38, -11.62 ]
Midanik 1991 74 -1.00 (15.80) 72 1.00 (17.30) 6.5 -2.00 [ -7.38, 3.38 ]
Rudd 2004 74 -14.20 (17.80) 76 -5.70 (18.40) 5.6 -8.50 [ -14.29, -2.71 ]
Total (95% CI) 914 946 100.0 -2.50 [ -3.87, -1.13 ]
Test for heterogeneity chi-square=26.66 df=9 p=0.002 I =66.2%
Test for overall effect z=3.59 p=0.0003
-10.0 -5.0 0 5.0 10.0
Favours treatment Favours control
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Analysis 01.02. Comparison 01 Active intervention versus control, Outcome 02 Self monitoring (diastolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 02 Self monitoring (diastolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bailey 1998 31 -6.00 (2.80) 29 -4.00 (2.80) 21.2 -2.00 [ -3.42, -0.58 ]
Carnahan 1975 49 -10.40 (9.80) 48 -10.40 (9.80) 2.8 0.00 [ -3.90, 3.90 ]
Friedman 1996 110 -5.20 (8.30) 123 -0.80 (8.00) 9.7 -4.40 [ -6.50, -2.30 ]
Haynes 1976 20 -5.40 (5.70) 18 -1.90 (5.40) 3.4 -3.50 [ -7.03, 0.03 ]
Johnson 1978 34 -8.50 (8.10) 34 -7.50 (11.30) 2.0 -1.00 [ -5.67, 3.67 ]
Mehos 2000 18 -10.50 (10.40) 18 -3.80 (9.30) 1.0 -6.70 [ -13.15, -0.25 ]
Rogers 2001 56 -1.90 (10.00) 55 2.10 (10.00) 3.1 -4.00 [ -7.72, -0.28 ]
Soghikian 1992 200 0.10 (9.10) 190 1.70 (10.20) 11.5 -1.60 [ -3.52, 0.32 ]
Vetter 2000 296 -13.20 (7.20) 326 -11.90 (6.90) 34.5 -1.30 [ -2.41, -0.19 ]
Artinian 2001 6 -14.00 (8.70) 9 -2.00 (9.90) 0.5 -12.00 [ -21.50, -2.50 ]
Midanik 1991 74 1.00 (9.40) 72 1.00 (8.40) 5.1 0.00 [ -2.89, 2.89 ]
Rudd 2004 74 -6.50 (9.90) 76 -3.40 (7.80) 5.2 -3.10 [ -5.96, -0.24 ]
Total (95% CI) 968 998 100.0 -2.03 [ -2.69, -1.38 ]
Test for heterogeneity chi-square=18.40 df=11 p=0.07 I =40.2%
Test for overall effect z=6.10 p<0.00001
-10.0 -5.0 0 5.0 10.0
Favours treatment Favours control
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Analysis 01.03. Comparison 01 Active intervention versus control, Outcome 03 Self monitoring (BP control)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 03 Self monitoring (BP control)
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Pierce 1984 15/55 7/29 5.8 1.18 [ 0.42, 3.32 ]
Rogers 2001 36/60 35/61 12.1 1.11 [ 0.54, 2.30 ]
Vetter 2000 100/296 131/326 71.8 0.76 [ 0.55, 1.05 ]
Earp 1982 29/74 16/47 10.3 1.25 [ 0.58, 2.68 ]
Total (95% CI) 485 463 100.0 0.88 [ 0.67, 1.15 ]
Total events: 180 (Treatment), 189 (Control)
Test for heterogeneity chi-square=2.30 df=3 p=0.51 I =0.0%
Test for overall effect z=0.96 p=0.3
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 01.11. Comparison 01 Active intervention versus control, Outcome 11 Patient education (systolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 11 Patient education (systolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Billault 1995 82 -2.70 (16.50) 85 -1.60 (14.60) 18.0 -1.10 [ -5.83, 3.63 ]
Burrelle 1986 8 -13.20 (16.00) 8 -5.80 (14.80) 1.8 -7.40 [ -22.50, 7.70 ]
Fielding 1994 74 -10.90 (19.30) 71 -2.40 (19.50) 10.1 -8.50 [ -14.82, -2.18 ]
Muhlhauser 1993 86 -8.00 (13.50) 74 -3.00 (13.90) 22.2 -5.00 [ -9.26, -0.74 ]
Roca-Cusachs 1991 84 -16.70 (18.50) 111 -18.00 (21.60) 12.7 1.30 [ -4.34, 6.94 ]
Watkins 1987 204 -0.20 (18.60) 210 -0.80 (18.60) 31.4 0.60 [ -2.98, 4.18 ]
Zismer 1982 26 -13.10 (13.90) 13 2.60 (16.20) 3.8 -15.70 [ -26.00, -5.40 ]
Total (95% CI) 564 572 100.0 -2.54 [ -4.55, -0.53 ]
Test for heterogeneity chi-square=16.45 df=6 p=0.01 I =63.5%
Test for overall effect z=2.48 p=0.01
-10.0 -5.0 0 5.0 10.0
Favours treatment Favours control
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Analysis 01.12. Comparison 01 Active intervention versus control, Outcome 12 Patient education (diastolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 12 Patient education (diastolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Billault 1995 82 1.30 (7.80) 85 -0.10 (11.20) 12.3 1.40 [ -1.52, 4.32 ]
Burrelle 1986 8 -4.10 (11.90) 8 -11.20 (13.10) 0.7 7.10 [ -5.16, 19.36 ]
Fielding 1994 74 -5.60 (9.70) 71 -1.70 (9.80) 10.4 -3.90 [ -7.07, -0.73 ]
Muhlhauser 1993 86 -5.00 (7.30) 74 -2.00 (8.20) 17.8 -3.00 [ -5.42, -0.58 ]
Roca-Cusachs 1991 84 -7.60 (9.50) 111 -9.50 (11.70) 11.8 1.90 [ -1.08, 4.88 ]
Tanner 1981 15 -3.70 (6.90) 15 -3.90 (6.90) 4.3 0.20 [ -4.74, 5.14 ]
Watkins 1987 204 0.30 (9.30) 210 -0.10 (9.30) 32.6 0.40 [ -1.39, 2.19 ]
Webb 1980 37 -6.80 (9.00) 55 -3.50 (8.40) 7.8 -3.30 [ -6.95, 0.35 ]
Zismer 1982 26 -8.20 (8.90) 13 0.50 (10.90) 2.2 -8.70 [ -15.54, -1.86 ]
Total (95% CI) 616 642 100.0 -0.81 [ -1.83, 0.21 ]
Test for heterogeneity chi-square=22.57 df=8 p=0.004 I =64.5%
Test for overall effect z=1.55 p=0.1
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Analysis 01.13. Comparison 01 Active intervention versus control, Outcome 13 Patient education (BP
control)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 13 Patient education (BP control)
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Earp 1982 14/41 16/47 17.9 1.00 [ 0.42, 2.43 ]
Morisky 1983 15/44 24/40 30.2 0.34 [ 0.14, 0.84 ]
Muhlhauser 1993 74/86 63/74 17.2 1.08 [ 0.44, 2.61 ]
Pierce 1984 10/59 9/27 18.7 0.41 [ 0.14, 1.17 ]
Sackett 1975 61/80 26/32 16.1 0.74 [ 0.27, 2.07 ]
Total (95% CI) 310 220 100.0 0.66 [ 0.44, 1.01 ]
Total events: 174 (Treatment), 138 (Control)
Test for heterogeneity chi-square=4.95 df=4 p=0.29 I =19.2%
Test for overall effect z=1.93 p=0.05
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Analysis 01.21. Comparison 01 Active intervention versus control, Outcome 21 Physician education (systolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 21 Physician education (systolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Coe 1977 60 -19.50 (21.10) 56 -18.30 (27.00) 2.5 -1.20 [ -10.06, 7.66 ]
Dickinson 1981 78 -10.00 (20.90) 33 -11.00 (23.80) 2.3 1.00 [ -8.35, 10.35 ]
Evans 1986 102 -12.20 (13.70) 81 -13.00 (19.60) 7.9 0.80 [ -4.23, 5.83 ]
Hetlevik 1999 816 -2.30 (19.10) 1023 -0.80 (18.30) 66.9 -1.50 [ -3.22, 0.22 ]
Montgomery 2000 199 -3.00 (18.10) 130 1.00 (20.30) 10.8 -4.00 [ -8.30, 0.30 ]
Sanders 2002 135 -7.10 (18.50) 126 -0.30 (18.90) 9.6 -6.80 [ -11.34, -2.26 ]
Total (95% CI) 1390 1449 100.0 -2.03 [ -3.45, -0.62 ]
Test for heterogeneity chi-square=7.06 df=5 p=0.22 I =29.2%
Test for overall effect z=2.83 p=0.005
-10.0 -5.0 0 5.0 10.0
Favours treatment Favours control
Analysis 01.22. Comparison 01 Active intervention versus control, Outcome 22 Physician education (diastolic
blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 22 Physician education (diastolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Coe 1977 60 -13.40 (13.20) 56 -14.50 (12.80) 2.1 1.10 [ -3.63, 5.83 ]
Dickinson 1981 78 -5.00 (13.90) 33 -4.00 (14.70) 1.4 -1.00 [ -6.89, 4.89 ]
Evans 1986 102 1.00 (6.90) 81 0.70 (8.60) 9.1 0.30 [ -2.00, 2.60 ]
Hetlevik 1999 816 -1.80 (9.30) 1023 -1.20 (8.50) 70.8 -0.60 [ -1.42, 0.22 ]
Montgomery 2000 199 -1.00 (9.10) 130 -2.00 (10.40) 10.0 1.00 [ -1.19, 3.19 ]
Sanders 2002 135 -3.40 (10.80) 126 -1.30 (11.50) 6.5 -2.10 [ -4.81, 0.61 ]
Total (95% CI) 1390 1449 100.0 -0.43 [ -1.12, 0.27 ]
Test for heterogeneity chi-square=4.08 df=5 p=0.54 I =0.0%
Test for overall effect z=1.20 p=0.2
-10.0 -5.0 0 5.0 10.0
Favours treatment Favours control
63Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Analysis 01.23. Comparison 01 Active intervention versus control, Outcome 23 Physician education (BP
control)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 23 Physician education (BP control)
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Dickinson 1981 14/78 3/16 0.2 0.95 [ 0.24, 3.78 ]
Evans 1986 42/102 37/81 1.4 0.83 [ 0.46, 1.50 ]
McAlister 1986 35/319 35/283 1.8 0.87 [ 0.53, 1.44 ]
Montgomery 2000 120/199 77/130 2.1 1.05 [ 0.67, 1.64 ]
Ornstein 2004 1850/4446 1600/3326 59.5 0.77 [ 0.70, 0.84 ]
New 2004 1282/2474 1319/2531 35.0 0.99 [ 0.88, 1.10 ]
Total (95% CI) 7618 6367 100.0 0.85 [ 0.80, 0.91 ]
Total events: 3343 (Treatment), 3071 (Control)
Test for heterogeneity chi-square=12.66 df=5 p=0.03 I =60.5%
Test for overall effect z=4.53 p<0.00001
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Analysis 01.31. Comparison 01 Active intervention versus control, Outcome 31 Health professional led care
(systolic blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 31 Health professional led care (systolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bogden 1998 49 -23.00 (22.60) 46 -11.00 (20.00) 2.8 -12.00 [ -20.57, -3.43 ]
Garcia-Pena 2001 345 -6.80 (17.40) 338 -3.50 (17.00) 30.4 -3.30 [ -5.88, -0.72 ]
Hawkins 1979 349 -2.00 (14.10) 280 -2.00 (10.70) 53.8 0.00 [ -1.94, 1.94 ]
Park 1996 23 -12.30 (15.80) 27 0.70 (18.80) 2.2 -13.00 [ -22.59, -3.41 ]
Solomon 2002 63 -8.20 (15.20) 70 -1.30 (19.00) 6.0 -6.90 [ -12.72, -1.08 ]
Tobe 2006 48 -24.00 (13.60) 47 -17.00 (18.10) 4.9 -7.00 [ -13.45, -0.55 ]
Total (95% CI) 877 808 100.0 -2.37 [ -3.79, -0.95 ]
Test for heterogeneity chi-square=20.11 df=5 p=0.001 I =75.1%
Test for overall effect z=3.27 p=0.001
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Analysis 01.32. Comparison 01 Active intervention versus control, Outcome 32 Health professional led care
(diastolic blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 32 Health professional led care (diastolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bogden 1998 49 -11.00 (9.40) 46 -3.00 (10.20) 2.0 -8.00 [ -11.95, -4.05 ]
Garcia-Pena 2001 345 -3.70 (9.20) 338 0.00 (9.60) 15.7 -3.70 [ -5.11, -2.29 ]
Hawkins 1979 349 -2.00 (5.30) 280 -2.00 (4.00) 59.2 0.00 [ -0.73, 0.73 ]
Logan 1979 206 -10.00 (6.40) 204 -6.10 (7.20) 18.0 -3.90 [ -5.22, -2.58 ]
Park 1996 23 -4.60 (8.50) 27 0.40 (9.30) 1.3 -5.00 [ -9.94, -0.06 ]
Solomon 2002 63 -4.40 (11.40) 70 -3.80 (11.00) 2.1 -0.60 [ -4.42, 3.22 ]
Tobe 2006 48 -1.60 (10.60) 47 -0.80 (10.90) 1.7 -0.80 [ -5.12, 3.52 ]
Total (95% CI) 1083 1012 100.0 -1.53 [ -2.09, -0.97 ]
Test for heterogeneity chi-square=51.03 df=6 p=<0.0001 I =88.2%
Test for overall effect z=5.37 p<0.00001
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Analysis 01.33. Comparison 01 Active intervention versus control, Outcome 33 Health professional led care
(BP control)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 33 Health professional led care (BP control)
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Bogden 1998 22/49 37/46 9.4 0.20 [ 0.08, 0.50 ]
Garcia-Pena 2001 220/345 316/338 51.7 0.12 [ 0.08, 0.20 ]
Jewell 1988 5/15 7/19 1.8 0.86 [ 0.21, 3.55 ]
Logan 1979 102/204 146/206 32.5 0.41 [ 0.27, 0.62 ]
Park 1996 11/23 21/26 4.6 0.22 [ 0.06, 0.78 ]
Total (95% CI) 636 635 100.0 0.24 [ 0.18, 0.32 ]
Total events: 360 (Treatment), 527 (Control)
Test for heterogeneity chi-square=17.34 df=4 p=0.002 I =76.9%
Test for overall effect z=10.19 p<0.00001
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Analysis 01.41. Comparison 01 Active intervention versus control, Outcome 41 Organisation/protocol driven
care (systolic blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 41 Organisation/protocol driven care (systolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bulpitt 1976 80 -28.80 (17.60) 71 -28.40 (17.10) 2.3 -0.40 [ -5.94, 5.14 ]
Dickinson 1981 51 -12.00 (19.70) 33 -11.00 (23.80) 0.8 -1.00 [ -10.76, 8.76 ]
Hypertension 1979 2872 -23.60 (16.20) 1718 -15.40 (17.50) 69.2 -8.20 [ -9.22, -7.18 ]
Takala 1979 39 -26.00 (18.40) 36 -29.00 (17.50) 1.1 3.00 [ -5.13, 11.13 ]
Takala 1983 36 -35.00 (18.50) 34 -38.00 (18.00) 1.0 3.00 [ -5.55, 11.55 ]
Hypertension 1979a 811 -38.90 (17.50) 542 -27.20 (18.60) 18.4 -11.70 [ -13.68, -9.72 ]
Hypertension 1982 438 -52.30 (21.90) 311 -41.70 (21.40) 7.3 -10.60 [ -13.74, -7.46 ]
Total (95% CI) 4327 2745 100.0 -8.55 [ -9.40, -7.70 ]
Test for heterogeneity chi-square=37.24 df=6 p=<0.0001 I =83.9%
Test for overall effect z=19.79 p<0.00001
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Analysis 01.42. Comparison 01 Active intervention versus control, Outcome 42 Organisation/protocol driven
care (diastolic blood pressure)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 42 Organisation/protocol driven care (diastolic blood pressure)
Study Treatment Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
Bulpitt 1976 80 -9.20 (8.80) 71 -9.40 (8.50) 2.0 0.20 [ -2.56, 2.96 ]
Dickinson 1981 51 -6.00 (9.90) 33 -4.00 (14.70) 0.5 -2.00 [ -7.70, 3.70 ]
Hypertension 1979 2872 -10.90 (7.30) 1718 -6.70 (8.10) 71.0 -4.20 [ -4.67, -3.73 ]
Takala 1979 39 -12.00 (9.20) 36 -15.00 (8.70) 0.9 3.00 [ -1.05, 7.05 ]
Takala 1983 36 -11.00 (9.20) 34 -16.00 (9.00) 0.9 5.00 [ 0.74, 9.26 ]
Hypertension 1979a 811 -20.80 (7.20) 542 -14.30 (9.00) 18.9 -6.50 [ -7.41, -5.59 ]
Hypertension 1982 438 -30.50 (9.80) 311 -22.90 (12.20) 5.8 -7.60 [ -9.24, -5.96 ]
Total (95% CI) 4327 2745 100.0 -4.58 [ -4.98, -4.19 ]
Test for heterogeneity chi-square=78.02 df=6 p=<0.0001 I =92.3%
Test for overall effect z=22.84 p<0.00001
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Analysis 01.43. Comparison 01 Active intervention versus control, Outcome 43 Organisation/protocol driven
care
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 43 Organisation/protocol driven care
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Dickinson 1981 15/51 3/16 0.2 1.81 [ 0.45, 7.27 ]
Fletcher 1975 36/74 33/70 0.8 1.06 [ 0.55, 2.04 ]
Hypertension 1979 1925/5485 3077/5455 97.7 0.42 [ 0.39, 0.45 ]
Sackett 1975 67/87 23/28 0.4 0.73 [ 0.25, 2.16 ]
Takala 1983 49/71 57/69 0.9 0.47 [ 0.21, 1.04 ]
Total (95% CI) 5768 5638 100.0 0.43 [ 0.40, 0.46 ]
Total events: 2092 (Treatment), 3193 (Control)
Test for heterogeneity chi-square=12.85 df=4 p=0.01 I =68.9%
Test for overall effect z=21.99 p<0.00001
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Analysis 01.51. Comparison 01 Active intervention versus control, Outcome 51 Appointment reminder
(appointment interventions) (outcome: lost to follow up at clinic)
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 01 Active intervention versus control
Outcome: 51 Appointment reminder (appointment interventions) (outcome: lost to follow up at clinic)
Study Treatment Control Odds Ratio (Fixed) Weight Odds Ratio (Fixed)
n/N n/N 95% CI (%) 95% CI
Ahluwalia 1996 8/53 6/54 2.2 1.42 [ 0.46, 4.42 ]
Barnett 1983 1/63 28/52 13.0 0.01 [ 0.00, 0.11 ]
Bloom 1979 12/27 20/27 4.8 0.28 [ 0.09, 0.88 ]
Cummings 1985 70/486 129/487 47.4 0.47 [ 0.34, 0.65 ]
Fletcher 1975 12/74 26/70 9.6 0.33 [ 0.15, 0.72 ]
Krieger 1999 51/146 88/165 23.1 0.47 [ 0.30, 0.74 ]
Total (95% CI) 849 855 100.0 0.41 [ 0.32, 0.51 ]
Total events: 154 (Treatment), 297 (Control)
Test for heterogeneity chi-square=16.91 df=5 p=0.005 I =70.4%
Test for overall effect z=7.66 p<0.00001
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